SunOpta (STKL) 10-K 28 Feb 24 2023 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2023	Feb. 23, 2024	Jul. 01, 2023
Entity Registrant Name	SUNOPTA INC.
Entity Shell Company	false
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	false
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2023
Amendment Flag	false
Document Period End Date	Dec. 30, 2023
Document Type	10-K
Entity Common Stock, Shares Outstanding		116,033,695
Entity Public Float			$ 650
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Filer Category	Large Accelerated Filer
Current Fiscal Year End Date	--12-30
Entity Central Index Key	0000351834
Entity File Number	001-34198
Entity Address, Address Line One	7078 Shady Oak Road
Entity Address, City or Town	Eden Prairie
Entity Address, State or Province	MN
Entity Address, Postal Zip Code	55344
City Area Code	952
Local Phone Number	820-2518
Entity Interactive Data Current	Yes
Entity Tax Identification Number	00-0000000
Entity Incorporation, State or Country Code	Z4
Document Transition Report	false
Document Annual Report	true
ICFR Auditor Attestation Flag	true
Auditor Name	Ernst & Young LLP
Auditor Location	Minneapolis
Auditor Firm ID	42
Document Financial Statement Error Correction [Flag]	false
The Nasdaq Stock Market | Common Shares
Trading Symbol	STKL
Security Exchange Name	NASDAQ
Title of 12(b) Security	Common Shares
The Toronto Stock Exchange | Common Shares
Trading Symbol	SOY
Title of 12(b) Security	Common Shares

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Income Statement [Abstract]
Revenues	$ 630,297	$ 591,395	$ 496,455
Cost of goods sold	541,680	491,665	415,311
Gross profit	88,617	99,730	81,144
Selling, general and administrative expenses	78,000	78,469	64,778
Intangible asset amortization	1,784	1,784	1,286
Other expense, net	455	1,651	6,745
Foreign exchange loss (gain)	110	(107)	94
Operating income	8,268	17,933	8,241
Interest expense, net	26,909	13,156	7,552
Earnings (loss) from continuing operations before income taxes	(18,641)	4,777	689
Income tax expense (benefit)	3,269	896	(4,854)
Earnings (loss) from continuing operations	(21,910)	3,881	5,543
Loss from discontinued operations, net of tax	(153,108)	(8,722)	(6,715)
Net loss	(175,018)	(4,841)	(1,172)
Dividends and accretion of preferred stock	(1,981)	(3,109)	(4,197)
Loss attributable to common shareholders	$ (176,999)	$ (7,950)	$ (5,369)
Basic and diluted earnings (loss) per share
Earnings (loss) from continuing operations (Basic)	$ (0.21)	$ 0.01	$ 0.01
Earnings (loss) from continuing operations	(0.21)	0.01	0.01
Loss from discontinued operations (Basic)	(1.34)	(0.08)	(0.06)
Loss from discontinued operations (diluted)	(1.34)	(0.08)	(0.06)
Earnings attributable to common shareholders	(1.55)	(0.07)	(0.05)
Diluted Earnings attributable to common shareholders	$ (1.55)	$ (0.07)	$ (0.05)
Weighted-average common shares outstanding (000s)
Basic	114,226	107,659	104,098
Diluted	114,226	110,247	106,987

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Statement of Comprehensive Income [Abstract]
Earnings (loss) from continuing operations	$ (21,910)	$ 3,881	$ 5,543
Loss from discontinued operations	(153,108)	(8,722)	(6,715)
Net loss	(175,018)	(4,841)	(1,172)
Other comprehensive loss
Reclassification of accumulated currency translation adjustment of discontinued operations	(646)	0	0
Other comprehensive loss	(646)	0	0
Comprehensive loss	$ (175,664)	$ (4,841)	$ (1,172)

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 306	$ 679
Accounts receivable, net of allowances for credit losses of $303 and $318, respectively	64,862	59,545
Inventories	83,215	74,439
Prepaid expenses and other current assets	25,235	15,535
Income taxes recoverable	4,717	4,040
Current assets held for sale	5,910	148,119
Total current assets	184,245	302,357
Restricted cash	8,448	0
Property, plant and equipment, net	319,898	292,306
Operating lease right-of-use assets	105,919	78,761
Intangible assets, net	21,861	23,646
Goodwill	3,998	3,998
Deferred income taxes	0	3,712
Other long-term assets	25,055	5,184
Non-current assets held for sale	0	145,888
Total assets	669,424	855,852
Current liabilities
Accounts payable and accrued liabilities	96,650	95,879
Notes payable	17,596	0
Income taxes payable	0	957
Current portion of long-term debt	24,346	38,491
Current portion of operating lease liabilities	15,808	12,499
Current liabilities held for sale	0	13,207
Total current liabilities	154,400	161,033
Long-term debt	238,883	269,993
Operating lease liabilities	100,102	74,329
Deferred income taxes	505	0
Non-current liabilities held for sale	0	3,228
Total liabilities	493,890	508,583
Series B-1 preferred stock	14,509	28,062
SHAREHOLDERS' EQUITY
Common shares, no par value, unlimited shares authorized, 115,953,287 shares issued (December 31, 2022 - 107,909,792)	464,169	440,348
Additional paid-in capital	27,534	33,184
Accumulated deficit	(332,687)	(155,688)
Accumulated other comprehensive income	2,009	1,363
Total shareholders' equity	161,025	319,207
Total liabilities and shareholders' equity	$ 669,424	$ 855,852

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($) shares in Thousands, $ in Thousands	Dec. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Allowances for credit losses	$ 303	$ 318
Common Stock, No Par Value	$ 0	$ 0
Common Stock Shares Issued	115,953,287	107,909,792

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Common shares [Member]	Additional paid-in capital [Member]	Accumulated deficit [Member]	Accumulated other comprehensive loss [Member]	Total
Balance at Jan. 02, 2021	$ 326,545	$ 37,862	$ (142,369)	$ 1,363	$ 223,401
Balance (in shares) at Jan. 02, 2021	90,194
Exchange of Series A preferred stock, net of share issuance costs of $287	$ 87,188				87,188
Number of shares issued for conversion preferred stock	12,633
Employee share purchase plan	$ 583				583
Employee share purchase plan (in shares)	67
Stock incentive plan	$ 22,147	(15,004)			7,143
Stock incentive plan (in shares)	4,466
Withholding taxes on stock-based awards		(8,718)			(8,718)
Stock-based compensation		9,100			9,100
Net earnings (loss)			(1,172)		(1,172)
Dividends on preferred stock			(3,477)		(3,477)
Accretion on preferred stock			(720)		(720)
Balance at Jan. 01, 2022	$ 436,463	23,240	(147,738)	1,363	313,328
Balance (in shares) at Jan. 01, 2022	107,360
Employee share purchase plan	$ 575				575
Employee share purchase plan (in shares)	88
Stock incentive plan	$ 3,310	(2,257)			1,053
Stock incentive plan (in shares)	462
Withholding taxes on stock-based awards		(1,629)			(1,629)
Stock-based compensation		13,830			13,830
Net earnings (loss)			(4,841)		(4,841)
Dividends on preferred stock			(2,436)		(2,436)
Accretion on preferred stock			(673)		(673)
Balance at Dec. 31, 2022	$ 440,348	33,184	(155,688)	1,363	319,207
Balance (in shares) at Dec. 31, 2022	107,910
Exchange of Series A preferred stock, net of share issuance costs of $287	$ 13,915				13,915
Number of shares issued for conversion preferred stock	6,089
Employee share purchase plan	$ 583				583
Employee share purchase plan (in shares)	121
Stock incentive plan	$ 9,323	(8,024)			1,299
Stock incentive plan (in shares)	1,833
Withholding taxes on stock-based awards		(9,404)			(9,404)
Stock-based compensation		11,778			11,778
Net earnings (loss)			(175,018)		(175,018)
Dividends on preferred stock			(1,428)		(1,428)
Accretion on preferred stock			(553)		(553)
Disposition of discontinued operations				646	646
Balance at Dec. 30, 2023	$ 464,169	$ 27,534	$ (332,687)	$ 2,009	$ 161,025
Balance (in shares) at Dec. 30, 2023	115,953

Consolidated Statements of Sh_2

Consolidated Statements of Shareholders' Equity (Parentheticals) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Income Statement [Abstract]
Share issuance cost	$ 191	$ 0	$ 287

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Operating activities
Net loss	$ (175,018)	$ (4,841)	$ (1,172)
Loss from discontinued operations	(153,108)	(8,722)	(6,715)
Earnings (loss) from continuing operations	(21,910)	3,881	5,543
Items not affecting cash:
Depreciation and amortization	31,039	23,047	18,627
Amortization of debt issuance costs	1,398	1,601	1,353
Deferred income taxes	3,978	(296)	(4,562)
Stock-based compensation	11,778	13,830	9,100
Loss on extinguishment of debt	1,584	0	0
Impairment of long-lived assets	0	0	3,202
Other	707	3,825	1,736
Changes in operating assets and liabilities, net of divestitures	(24,999)	(15,142)	3,208
Net cash provided by operating activities of continuing operations	3,575	30,746	38,207
Net cash provided by (used in) operating activities of discontinued operations	11,269	29,829	(59,639)
Net cash provided by (used in) operating activities	14,844	60,575	(21,432)
Investing activities
Additions to property, plant and equipment	(46,125)	(125,139)	(54,617)
Cash settlement of foreign currency forward contract	(394)	0	0
Proceeds from sale of property, plant and equipment	0	4,182	2,300
Additions to intangible assets	0	0	(25,073)
Net cash used in investing activities of continuing operations	(46,519)	(120,957)	(77,390)
Net cash provided by (used in) investing activities of discontinued operations	90,551	14,133	(17,060)
Net cash provided by (used in) investing activities	44,032	(106,824)	(94,450)
Financing activities
Increase (decrease) in borrowings under revolving credit facilities	(15,863)	29,640	45,119
Borrowings of long-term debt	199,855	90,907	25,232
Repayment of long-term debt	(95,303)	(20,085)	(8,502)
Repayment of asset-based credit facilities	(141,880)	0	0
Payment of debt issuance costs	(3,297)	(735)	(2,561)
Proceeds from notes payable	102,043	0	0
Repayment of notes payable	84,447	0	0
Proceeds from the exercise of stock options and employee share purchases	1,882	1,628	7,726
Payment of withholding taxes on stock-based awards	(9,404)	(1,629)	(8,718)
Payment of cash dividends on preferred stock	(1,732)	(2,436)	(5,247)
Payment of common share issuance costs	(191)	0	(287)
Payment of preferred stock issuance costs	0	(756)	0
Net cash provided by (used in) financing activities of continuing operations	(48,337)	96,534	52,762
Net cash provided by (used in) financing activities of discontinued operations	(2,464)	(49,833)	63,096
Net cash provided by (used in) financing activities	(50,801)	46,701	115,858
Increase (decrease) in cash, cash equivalents and restricted cash during the year	8,075	452	(24)
Cash and cash equivalents, beginning of the year	679	227	251
Cash, cash equivalents and restricted cash, end of the year	$ 8,754	$ 679	$ 227

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Dec. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Significant Accounting Policies [Text Block]	1. Significant Accounting Policies Basis of Presentation These consolidated financial statements include the accounts of SunOpta Inc. and those of its wholly-owned subsidiaries (collectively, the "Company" or "SunOpta") and have been prepared by the Company in United States ("U.S.") dollars and in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). All intercompany accounts and transactions have been eliminated on consolidation. Fiscal Year The fiscal year of the Company consists of a 52- or 53-week period ending on the Saturday closest to December 31. Fiscal years 2023, 2022 and 2021 were each 52-week periods ending on December 30, 2023, December 31, 2022 and January 1, 2022, respectively. Fiscal year 2024 will be a 52-week period ending on December 28, 2024, with quarterly periods ending on March 30, 2024, June 29, 2024, and September 28, 2024. Discontinued Operations As described in note 2, on October 12, 2023, the Company completed the divestiture of its frozen fruit business ("Frozen Fruit"). The divestiture of Frozen Fruit completes the Company's strategic optimization plan for its non-core, commodity-based businesses, which included the divestiture of its sunflower business ("Sunflower") in October 2022, in order to focus on value-add products in plant-based and healthy snack categories. Beginning in the third quarter of 2023, Frozen Fruit and Sunflower met the criteria for reporting as discontinued operations, and, as such, the operating results and cash flows of Frozen Fruit and Sunflower for the years ended December 31, 2022 and January 1, 2022 have been reclassified to discontinued operations on the consolidated statements of operations and cash flows, and the assets and liabilities of the Frozen Fruit disposal group have been reclassified and reported as held for sale on the consolidated balance sheet as at December 31, 2022. In addition, the information disclosed in these notes to the consolidated financial statements is presented on a continuing operations basis, with comparative period information recast to reflect Frozen Fruit and Sunflower as discontinued operations. Segment Information In connection with the divestiture of Frozen Fruit, the Company changed its internal organization and reporting structures beginning in the third quarter of 2023 and began operating as one segment. These changes included the elimination of the roles and responsibilities of the former General Managers of the Company, who were previously identified as the segment managers of the Company's former Plant-Based and Fruit-Based Foods and Beverages operating and reportable segments. With these changes, the Company's Chief Executive Officer, who has been identified as the Chief Operating Decision Maker ("CODM"), manages operations on a company-wide basis, rather than at a product category or business unit level. The CODM is supported by a centralized management team based on functional area, including sales, marketing, supply chain, and research and development, as well as finance, IT and administration. Only the CODM has overall responsibility and accountability for the profitability and cash flows of the Company. Using financial information at the consolidated level, the CODM makes key operating decisions, including approving annual operating plans, expanding into new markets or product categories, pursuing business acquisitions or divestitures, and initiating major capital expenditure programs. In addition, the CODM determines the allocation of resources and capital investments to optimize operations and maximize opportunities for the Company as a whole, without regard to specific product categories or business units. The CODM also uses consolidated information to assess performance against the annual operating plan and to set company-wide incentive compensation targets. Following the divestiture of its commodity-based businesses, the majority of the Company's products are shelf-stable packaged food and beverage products and share similar customers and distribution. Refer to note 18 for a disaggregation of the Company's revenues by product category. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Areas involving significant estimates and assumptions include: allowances for credit losses; inventory reserves; income tax liabilities and assets, and related valuation allowances; provisions for loss contingencies related to claims and litigation; useful lives of property, plant and equipment and intangible assets; expected lease terms and discount rates in measuring lease assets and liabilities; expected future cash flows used in evaluating long-lived assets for impairment; and reporting unit fair values in testing goodwill for impairment. The estimates and assumptions made require judgment on the part of management and are based on the Company's historical experience and various other factors that are believed to be reasonable in the circumstances. Management continually evaluates the information that forms the basis of its estimates and assumptions as the business of the Company and the general business environment changes. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (that is, an exit price). Fair value measurements are estimated based on inputs categorized as follows: Level 1 inputs include quoted prices (unadjusted) for identical assets or liabilities in active markets that are observable. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 includes unobservable inputs that reflect the Company's own assumptions about what factors market participants would use in pricing the asset or liability. When measuring fair value, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs. Foreign Currency Transactions Gains or losses resulting from transactions denominated in foreign currencies are included in foreign exchange gain/loss on the consolidated statements of operations. Cash and Cash Equivalents Cash and cash equivalents consist of cash and short-term deposits with an original maturity of 90 days or less. The Company places its cash and cash equivalents with institutions of high creditworthiness. Restricted Cash Restricted cash consists of cash that is legally restricted as to withdrawal or usage. Accounts Receivable Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for credit losses is an estimate of the amount of probable losses in existing accounts receivable. The Company routinely assesses the financial strength of its customers and believes that its accounts receivable credit risk exposure is limited. The Company closely monitors receivable balances and estimates an allowance for credit losses based on historical collection experience, and account aging analysis and trends, and evaluates the adequacy of the allowance each reporting period, considering individual customer account reviews, write-offs recorded in the period, sales forecasts and trends, and current and expected economic and customer-specific conditions. Account balances are charged off against the allowance when the Company determines the receivable will not be recovered. As at December 30, 2023, two long-term customers represented approximately 33% and 14%, respectively, of the Company's consolidated accounts receivable balance. The Company does not believe it is exposed to any significant credit risks with respect to these customers. Inventories Inventories are valued at the lower of cost and net realizable value on a first-in, first-out basis. Shipping and handling costs are included in cost of goods sold on the consolidated statements of operations. Property, Plant and Equipment Property, plant and equipment assets are stated at cost, less accumulated depreciation. Cost includes capitalized interest on borrowings during the construction of major capital projects. Depreciation begins when an asset is ready for its intended use. Property, plant and equipment assets, other than land, are depreciated on a straight-line basis over the estimated useful lives of the assets, as follows: Buildings 20 - 40 years Machinery and equipment 5 - 20 years Enterprise software 3 - 5 years Office furniture and equipment 3 - 7 years Vehicles 3 - 7 years Leases At the lease commencement date, the Company recognizes a right-of-use lease asset for an amount equal to the lease liability, less any lease incentives. The lease liability is determined based on the present value of future lease payments over the lease term. The lease term includes the noncancellable term of the lease, together with periods covered by options to extend the lease that the Company is reasonably certain to exercise. The discount rate used to determine the present value of the future lease payments is the implicit rate in the lease if readily determinable. When that rate is not readily determinable, the Company applies its incremental borrowing rate, which its estimated using relevant interest rate yield curves and credit spreads derived from available market data. The Company excludes material non-lease components in determining the future lease payments. Material leases with an initial term of 12 months or less are recorded on the balance sheet. Intangible Assets The Company's finite-lived intangible assets consist of brand names and customer relationships. Intangible assets are amortized on a straight-line basis over their estimated useful lives, which are 15 years for brand names and 20 years for customer relationships. Impairment of Long-Lived Assets The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If the carrying amount of an asset is not recoverable, the fair value of the asset is determined typically using an income approach (discounted cash flow analysis). An impairment loss is recognized in earnings for any excess of the carrying amount of the asset over its fair value. Goodwill Goodwill represents the excess in a business combination of the purchase price over the estimated fair value of the identifiable net assets acquired. Goodwill is not amortized but is instead tested for impairment at the reporting unit level at least annually, or whenever events or circumstances change between the annual impairment tests that would indicate the carrying amount of goodwill may be impaired. The Company performs its annual test for goodwill impairment in the fourth quarter of each fiscal year. The Company can elect to qualitatively assess goodwill for impairment if it is more likely than not that the fair value of a reporting unit exceeds its carrying value. If the Company elects to quantitatively assess goodwill, or it is not more likely than not that the fair value of a reporting unit exceeds its carrying value, the Company estimates the fair value of each of its reporting units using an income approach (discounted cash flow method). Goodwill impairment charges are recognized based on the excess of a reporting unit's carrying amount over its fair value. Based on Company's qualitative assessment, it was determined that goodwill was not impaired as at December 30, 2023. Debt Issuance Costs Costs incurred in connection with obtaining debt financing are deferred and amortized over the term of the financing arrangement. Costs incurred to secure revolving credit facilities are recorded in other long-term assets. All other debt issuance costs are recorded as a direct deduction from the related debt liability. Income Taxes The Company follows the asset and liability method of accounting for income taxes whereby deferred income tax assets are recognized for deductible temporary differences and operating loss carryforwards, and deferred income tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the amounts of assets and liabilities recorded for income tax and financial reporting purposes. Deferred income tax assets are recognized only to the extent that management determines that it is more likely than not that the deferred income tax assets will be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The income tax expense or benefit is the income tax payable or recoverable for the year plus or minus the change in deferred income tax assets and liabilities during the year. The Company is subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, the Company may incur additional income tax expense based upon the outcomes of such matters. In addition, when applicable, the Company adjusts income tax expense to reflect the Company's ongoing assessments of such matters, which requires judgment and can materially increase or decrease its effective rate as well as impact operating results. The evaluation of tax positions taken or expected to be taken in a tax return is a two-step process, whereby (i) the Company determines whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and (ii) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the related tax authority. Stock Incentive Plan The Company maintains a stock incentive plan under which stock options and other stock-based awards may be granted to selected employees and directors. The Company measures stock-based awards at fair value as of the date of grant. Compensation expense is recognized on a straight-line basis over vesting period of the entire stock-based award, based on the number of awards that ultimately vest. Upon exercise, stock-based awards are settled through the issuance of common shares and are therefore treated as equity awards. Revenue Recognition The Company manufactures and sells food and beverage products to retailers, foodservice operators, branded food companies, and other food manufacturers. The Company recognizes revenue when performance obligations under the terms of a contract with a customer are satisfied, which is upon the transfer of control of the contracted goods. Except for goods sold under bill-and-hold arrangements, control is transferred when title and physical possession of the product transfers to the customer, which is at the point in time that product is shipped from the Company's facilities or delivered to a specified destination, depending on the terms of the contract, and the Company has a present right to payment. Under bill-and-hold arrangements, whereby the Company bills a customer for product to be delivered at a later date, control typically transfers when the product is ready for physical transfer to the customer, and the Company has a present right to payment. A performance obligation is a promise within a contract to transfer distinct goods to the customer. A contract with a customer may involve multiple products and/or multiple delivery dates, with the transfer of each product at each delivery date being considered a distinct performance obligation, as each of the Company's products has standalone utility to the customer. In these cases, the contract's transaction price is allocated to each performance obligation based on relative standalone selling prices and recognized as revenue when each individual product is transferred to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods. Consideration is typically determined based on a fixed unit price for the quantity of product transferred. Certain contracts include rebates and other forms of variable consideration. For contracts involving variable consideration, the Company estimates the transaction price based on the amount of consideration to which it expects to be entitled. These estimates are determined based on historical experience and the expected outcome of the variable consideration, and are updated as new information becomes available, including actual claims paid, which indicate an estimate is not indicative of the expected results. Changes to these estimates are recorded in the period the adjustment is identified. The Company does not typically grant customers a general right of return for goods transferred but will generally accept returns of product for quality-related issues. The cost of satisfying this promise of quality is accounted for as an assurance-type warranty obligation rather than variable consideration. The Company's contracts do not typically include any significant payment terms, as payment is normally due shortly after the time of transfer. Revenue contracts are typically represented by short-term, binding purchase orders from customers, identifying the quantity and pricing for products to be transferred. Customer purchase orders may be issued under long-term master supply arrangements. On their own, these master supply arrangements are typically not considered contracts for purposes of revenue recognition, as they do not create enforceable rights and obligations regarding the quantity, pricing, or timing of goods to be transferred; however, certain master supply agreements impose minimum purchase obligations on the part of the customers, which is considered a form of variable consideration. Other master supply arrangements provide for the transfer of product on a bill-and-hold basis at the specific request of the customer. As goods are produced under these bill-and-hold arrangements to meet individual customer specifications, they are identifiable as belonging to the customer and cannot be directed to another customer. The timing of the Company's revenue recognition, customer billings and cash collections, does not result in significant unbilled receivables (contract assets) or customer advances (contract liabilities) on the consolidated balance sheet. Contract costs, such as sales commissions, are generally expensed as incurred given the short-term nature of the associated contracts. Advertising Costs Advertising costs are expensed as incurred and are included in selling, general and administrative expenses. Research and Development Costs Research and development costs are expensed as incurred and are included in selling, general and administrative expenses. The Company's research and development activities are directed towards custom product formulations, packaging innovations, and production process improvements. The Company's research and development expenditures primarily consist of employee-related compensation and supplies, as well as rental costs and depreciation expense related to the Company's innovation center and pilot plant. Earnings Per Share Basic earnings per share is computed by dividing earnings available to common shareholders by the weighted-average number of common shares outstanding during the year. Earnings attributable to common shareholders is computed by deducting dividends and accretion on convertible preferred stock from net earnings. The potential diluted effect of stock options and other stock-based awards is computed using the treasury stock method whereby the weighted-average number of common shares used in the basic earnings per share calculation is increased to include the number of additional common shares that would have been outstanding if the potential dilutive common shares had been issued at the beginning of the year. The potential dilutive effect of convertible preferred stock is computed using the if-converted method whereby dividends and accretion on the convertible preferred stock are added back to the numerator, and the common shares resulting from the assumed conversion of the convertible preferred stock are included in the denominator of the diluted earnings per share calculation. Contingencies In the normal course of business, the Company is subject to loss contingencies, such as accrued but unpaid bonuses, tax-related matters, product recall-related claims and recoveries, and other claims or litigation. Accruals for loss contingencies are recorded when the Company determines that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. If the estimate of the amount of the loss is a range and some amount within the range appears to be a better estimate than any other amount within the range, that amount is accrued as a liability. If no amount within the range is a better estimate than any other amount, the minimum amount of the range is accrued as a liability. Recent Accounting Pronouncements In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures

Discontinued Operations

Discontinued Operations	12 Months Ended
	Dec. 30, 2023
Divestiture of Frozen Fruit [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Discontinued Operations [Text Block]	2. Discontinued Operations Divestiture of Frozen Fruit On October 12, 2023, the Company, together with its subsidiaries Sunrise Growers, Inc. ("Sunrise Growers"), Sunrise Growers Mexico, S. de R.L. de C.V. ("Sunrise Mexico") and SunOpta Mx, S.A. de C.V. ("SunOpta Mexico"), entered into an Asset Purchase Agreement ("APA") with Natures Touch Mexico, S. de R.L. de C.V. and Nature's Touch Frozen Fruits, LLC (the "Purchasers") to sell to the Purchasers certain assets and liabilities of Frozen Fruit (the "Transaction"). On October 12, 2023 (the "Closing Date"), the Company completed the Transaction in accordance with the terms of the APA. The Transaction represents the Company's exit from the processing, packaging and selling of individually quick frozen fruit for retail, foodservice and industrial applications. Frozen Fruit was previously identified as At the Closing Date, the estimated aggregate purchase price comprised cash consideration of $95.3 million; a short-term note receivable of $10.5 million, payable in five consecutive monthly installments of $2.1 million beginning 30 days following the Closing Date; secured seller promissory notes due in three years and with stated principal amounts of $15.0 million entered into by Sunrise Growers and $5.0 million entered into by SunOpta Mexico (the "Seller Promissory Notes"); and the assumption by the Purchasers of $15.7 million of accounts payable and accrued liabilities of Frozen Fruit. At the Closing Date, $20.5 million of the cash consideration was used to make required repayments of certain bank loans and other liabilities of Frozen Fruit not assumed by the Purchasers. The Company realized a $0.4 million loss on a foreign currency forward contract entered into to hedge the repayment of Mexican peso-denominated bank loans, which is included in other expense of continuing operations. The Company utilized the remaining cash consideration of $74.8 million to repay a portion of the outstanding borrowings under its credit agreement. As at December 30, 2023, $6.3 million of the short-term note receivable remained outstanding, which is included in other current assets on the consolidated balance sheet. The estimated aggregate purchase price is subject to post-closing adjustments based on a determination of the final net working capital and resulting aggregate purchase price as of the Closing Date (the "Closing Statement"), with adjustments to the aggregate purchase price determined on a separate and individual basis for each of Sunrise Growers, Sunrise Mexico and SunOpta Mexico. Any downward adjustment will be deducted from the principal amount of the Seller Promissory Notes entered into by Sunrise Growers and/or SunOpta Mexico, as the case may be, in an amount up to $5.0 million in the aggregate, with any additional downward adjustment payable by the Company to the Purchasers in cash. The portion of any upward adjustment in the aggregate purchase price not paid to the Company by the Purchasers in cash will be added to the principal amount of the Seller Promissory Notes entered into by Sunrise Growers and/or SunOpta Mexico, as applicable. As at December 30, 2023, the Company recorded a $0.5 million net receivable from the Purchasers based on the Company's estimate of the final net working capital and post-closing adjustments, which is included in other current assets on the consolidated balance sheet. However, this estimate may be subject to change, which could be material, as the parties are currently in the process of reconciling the final aggregate purchase price, including the resolution of certain disputed items in accordance with the procedures set forth in the APA. The Seller Promissory Notes bear interest at a rate per annum equal to the Secured Overnight Financing Rate ("SOFR"), determined quarterly in advance, plus a margin of 4.00% for the first year and 7.00% for the second and third years. Interest is payable quarterly in-kind. The Seller Promissory Notes mature on October 12, 2026, and outstanding principal and accrued and unpaid interest is payable on the maturity date. The Seller Promissory Notes are measured at fair value on a nonrecurring basis (Level 3 within the fair value hierarchy) and will be assessed for credit losses periodically. The Company determined that the fair values of the Seller Promissory Notes approximate their principal values upon initial recognition and no premium or discount was recognized. As described above, the final principal amount of the Sellers Promissory Notes may change as a result of any upward or downward adjustment to the aggregate purchase price in connection with the resolution of the Closing Statement. As at December 30, 2023, the Company has not recorded any allowance for credit losses related to the Seller Promissory Notes. The Seller Promissory Notes are secured by a second-priority lien on certain assets of Frozen Fruit acquired by the Purchasers. The principal amount of the Seller Promissory Notes, together with accrued and unpaid in-kind interest, is recorded in other long-term assets on the consolidated balance as at December 30, 2023. On the Closing Date, the Company entered into post-closing transitional services agreements with the Purchasers to facilitate an orderly transfer of the business operations. The services provided under the agreements include, but are not limited to, information technology and financial shared services, payroll and benefits administration, supply chain transition services, and contract manufacturing. These services terminate at various times up to nine months from the Closing Date and certain services may be extended up to an additional three months. Internal labor and third-party costs incurred by the Company to provide these services are recoverable from the Purchasers as incurred, including a mark-up on manufacturing services. Reverse transition services to be provided by the Purchasers include, but are not limited to, support for the sell-through of the frozen fruit inventory that was not acquired by the Purchasers, in exchange for a broker fee on sales of the retained inventory to third parties. The Company recognized a pre-tax loss on divestiture of $119.8 million, including costs to sell, related to the net assets of the Transaction disposal group, which is recognized as part of the loss from discontinued operations in the consolidated statement of operations for the year ended December 30, 2023. The table below presents the major components of the results of discontinued operations reported in the consolidated statement of operations for each of the three years in the period ended December 30, 2023. The results of operations for the years ended December 31, 2022 and January 1, 2022 include the results of Sunflower, which prior to the divestiture of Frozen Fruit did not qualify on a quantitative basis for reporting as discontinued operations on a standalone basis. December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Revenues 200,029 343,267 316,169 Cost of goods sold (1) 211,467 320,143 299,593 Selling, general and administrative expenses (2) 8,683 10,843 11,821 Intangible asset amortization 6,000 8,498 8,664 Other expense (income), net (3) 10,112 (2,746 ) 2,145 Foreign exchange loss (gain) (3,333 ) (1,641 ) 1,018 Interest expense, net (4) 554 1,578 1,217 Earnings (loss) before loss on divestiture (33,454 ) 6,592 (8,289 ) Pre-tax loss on divestiture (5) (119,821 ) (31,468 ) - Loss from discontinued operations before income taxes (153,275 ) (24,876 ) (8,289 ) Income tax benefit (6) (167 ) (16,154 ) (1,574 ) Loss from discontinued operations (153,108 ) (8,722 ) (6,715 ) (1) (2) (3) (4) (5) (6) The table below presents the net assets of Frozen Fruit that have been reclassified and reported as held for sale on the consolidated balance sheets as at December 30, 2023 and December 31, 2022. December 30, 2023 December 31, 2022 $ $ Assets Accounts receivable - 15,358 Inventories (1) 5,910 132,608 Other current assets - 153 Property, plant and equipment, net - 30,085 Operating lease right-of-use assets - 3,803 Intangible assets, net - 112,000 Total assets held for sale 5,910 294,007 Liabilities Accounts payable and accrued liabilities - 12,632 Operating lease liabilities - 3,803 Total liabilities held for sale - 16,435 (1) As at December 30, 2023, inventories held for sale reflect the remaining carrying value of the frozen fruit inventory that was not acquired by the Purchasers.

Inventories

Inventories	12 Months Ended
	Dec. 30, 2023
Inventory Disclosure [Abstract]
Inventories [Text Block]	3. Inventories December 30, 2023 December 31, 2022 $ $ Raw materials and work-in-process 52,419 46,723 Finished goods 37,606 31,014 Inventory reserve (6,810 ) (3,298 ) 83,215 74,439 The change in the inventory reserve for the years ended December 30, 2023 and December 31, 2022 is comprised as follows: December 30, 2023 December 31, 2022 $ $ Balance, beginning of year 3,298 1,604 Additions to reserve during the year 9,255 5,625 Reserves applied and inventories written off during the year (5,743 ) (3,931 ) Balance, end of year 6,810 3,298

Restricted Cash

Restricted Cash	12 Months Ended
	Dec. 30, 2023
Restricted Cash and Cash Equivalents [Abstract]
Restricted Cash [Text Block]	4. Restricted Cash Restricted cash relates to certain bank accounts in Mexico that were retained following the divestiture of Frozen Fruit, which are subject to a judicial hold in connection with a litigation matter. Restricted cash has been classified as non-current on the consolidated balance sheet as at December 30, 2023, as the Company cannot predict the timing of when this matter may be resolved.

Property, Plant and Equipment

Property, Plant and Equipment	12 Months Ended
	Dec. 30, 2023
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Text Block]	5. Property, Plant and Equipment The major components of property, plant and equipment as at December 30, 2023 and December 31, 2022 were as follows: December 30, 2023 December 31, 2022 Cost Accumulated Net book Cost Accumulated Net book $ $ $ $ $ $ Land 238 - 238 238 - 238 Buildings 102,211 21,641 80,570 104,835 16,721 88,114 Machinery and equipment 323,653 95,254 228,399 271,877 78,029 193,848 Enterprise software 16,847 8,156 8,691 22,717 14,750 7,967 Office furniture and equipment 3,568 1,715 1,853 3,719 1,767 1,952 Vehicles 405 258 147 492 305 187 446,922 127,024 319,898 403,878 111,572 292,306 Interest expense capitalized as part of the construction cost of property, plant and equipment was $0.3 million and $1.2 million for the years ended December 30, 2023 and December 31, 2022, respectively, and immaterial for the year ended January 1, 2022. As at December 30, 2023, property, plant and equipment included construction in process assets of $33.3 million (December 31, 2022 - $128.4 million) and $11.1 million (December 31, 2022 - $8.8 million) of spare parts inventory. Total depreciation expense included in cost of goods sold and selling, general and administrative expenses on the consolidated statements of operations related to property, plant and equipment for the year ended December 30, 2023 was $29.3 million (December 31, 2022 - $21.3 million; January 1, 2022 - $17.3 million).

Leases

Leases	12 Months Ended
	Dec. 30, 2023
Leases [Abstract]
Leases [Text Block]	6. Leases The Company leases certain manufacturing plants, warehouses, offices, and machinery and equipment. At the lease commencement date, the Company classifies a lease as a finance lease if it has the right to obtain substantially all of the economic benefits from the right-of-use assets, otherwise the lease is classified as an operating lease. The Company's leases have remaining noncancelable lease terms of less than one year to approximately 15 years, and typically require fixed monthly rental payments that may be adjusted annually to give effect to inflation. Real estate leases typically provide the Company options to extend the leases for up to 15 years. Finance leases for machinery and equipment typically include nominal purchase options at the end of the lease term that are reasonably certain of being exercised at the lease commencement date. Machinery and equipment operating leases typically include purchase options for the fair market value of the underlying asset at the end of the lease term, which are uncertain of being exercised at the lease commencement date. The following tables present supplemental information related to leases: December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Lease Costs Operating lease cost 15,076 13,099 11,789 Finance lease cost: Depreciation of right-of-use assets 13,441 9,816 5,592 Interest on lease liabilities 9,310 5,136 2,727 Total finance lease cost 22,751 14,952 8,319 December 30, 2023 December 31, 2022 $ $ Balance Sheet Classification Operating leases: Operating lease right-of-use assets 105,919 78,761 Current portion of operating lease liabilities 15,808 12,499 Operating lease liabilities 100,102 74,329 Total operating lease liabilities 115,910 86,828 Finance leases: Property, plant and equipment, gross 81,423 153,976 Accumulated depreciation (18,319 ) (18,168 ) Property, plant and equipment, net 63,104 135,808 Current portion of long-term debt 15,346 33,283 Long-term debt 37,284 90,796 Total finance lease liabilities 52,630 124,079 December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Cash Flow Information Cash paid (received) for amounts included in measurement of lease liabilities: Operating cash flows from operating leases 13,852 12,320 11,098 Operating cash flows from finance leases 9,310 5,136 2,727 Financing cash flows from finance leases Cash paid under finance leases (1) 89,087 19,903 8,439 Cash received under finance leases (2) (6,568 ) (58,764 ) (13,626 ) Right-of-use assets obtained in exchange for lease liabilities: Operating leases 35,601 49,662 27,909 Finance leases 9,651 31,466 29,906 Right-of-use assets and liabilities reduced through lease terminations or modifications: Operating leases (914 ) (4,060 ) (2,261 ) (1) Represents repayments under finance leases recorded as a reduction of the lease liability and reported in repayment of long-term debt on the consolidated statements of cash flows. For the year ended December 30, 2023, lease repayments include $56.0 million paid by the Company to terminate certain finance lease obligations and purchase the related underlying right-of-use assets in connection with the refinancing of the Company's credit facilities on December 8, 2023 (see note 10). The difference of $4.4 million between the purchase price and the carrying amount of the finance lease obligations is reported in additions to property, plant and equipment on the consolidated statement of cash flows for the year ended December 30, 2023. (2) Represents cash advances received by the Company under finance leases for the construction of right-of-use assets controlled by the Company, which related to the buildouts of the Company's new plant-based beverage facility in Midlothian, Texas, and the Company's executive office and innovation center located in Eden Prairie, Minnesota, as well as cash proceeds under sale and leaseback transactions accounted for as financings. Cash received under finance leases is reported in borrowings of long-term debt on the consolidated statements of cash flows. December 30, 2023 December 31, 2022 January 1, 2022 Other Information Weighted-average remaining lease term (years): Operating leases 12.0 12.9 7.6 Finance leases 3.2 3.5 4.3 Weighted-average discount rate: Operating leases 8.7% 8.8% 5.1% Finance leases 7.9% 8.2% 6.6% Operating leases Finance leases $ $ Maturities of Lease Liabilities 2024 16,364 17,834 2025 16,410 20,199 2026 15,564 16,423 2027 14,559 4,458 2028 14,374 1,398 Thereafter 167,412 - Total lease payments 244,683 60,312 Less: imputed interest (128,773 ) (7,682 ) Total lease liabilities 115,910 52,630 As at December 30, 2023, the Company had entered into a finance lease agreement to provide for approximately $25 million of financing related to an expansion of the Company's ingredient extraction operations at its Modesto, California, facility, which is expected to become operational during the first half of 2024. As this finance lease had not commenced as at December 30, 2023, no amount of underlying right-of-use assets, or lease liabilities, were recognized on the consolidated balance sheet as of that date.

Intangible Assets

Intangible Assets	12 Months Ended
	Dec. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets [Text Block]	7. Intangible Assets The gross carrying amounts and accumulated amortization of intangible assets as at December 30, 2023 and December 31, 2022 were as follows: December 30, 2023 December 31, 2022 Cost Accumulated Net book Cost Accumulated Net book $ $ $ $ $ $ Brand names 25,073 4,517 20,556 25,073 2,845 22,228 Customer relationships 2,251 946 1,305 2,251 833 1,418 27,324 5,463 21,861 27,324 3,678 23,646 Amortization expense associated with intangible assets in each of the next five fiscal years and thereafter is as follows: 2024 2025 2026 2027 2028 Thereafter Total $ $ $ $ $ $ $ Amortization expense 1,784 1,784 1,784 1,784 1,784 12,941 21,861

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	12 Months Ended
	Dec. 30, 2023
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities [Text Block]	8. Accounts Payable and Accrued Liabilities December 30, 2023 December 31, 2022 $ $ Accounts payable 75,761 76,025 Payroll and benefits 11,841 13,639 Accrued interest 1,379 1,685 Accrued severance costs 1,273 - Accrued product recall-related costs (see note 17) 1,250 - Dividends payable on preferred stock (see note 11) 304 609 Other accruals 4,842 3,921 96,650 95,879

Notes Payable

Notes Payable	12 Months Ended
	Dec. 30, 2023
Payables and Accruals [Abstract]
Notes Payable [Text Block]	9. Notes Payable Commencing in 2023, the Company is financing certain purchases of trade goods and services through third-party extended payables facilities. Under these facilities, third-party intermediaries advance the amount of the scheduled payment to the supplier based on the invoice due date and issue a short-term note payable to the Company for the face amount of the supplier invoice. Interest accrues on the note payable from the contractual payment date of the supplier invoice to the extended due date of the note payable, as specified by the negotiated terms of each facility. The Company does not maintain any form of security with the third-party intermediaries. As at December 30, 2023, the Company had outstanding principal payment obligations to the third-party intermediaries of $17.6 million in the aggregate, which is recorded as notes payable on the Company's consolidated balance sheet. Proceeds from, and repayments of the notes payable associated with, these facilities are reported as financing cash flows on the Company's consolidated statements of cash flows.

Long-Term Debt

Long-Term Debt	12 Months Ended
	Dec. 30, 2023
Debt Disclosure [Abstract]
Long-Term Debt [Text Block]	10. Long-Term Debt December 30, 2023 December 31, 2022 $ $ Term loan facilities 180,000 43,748 Revolving credit facilities 31,751 137,253 Less: Unamortized debt issuance costs (1,152 ) - Total credit facilities 210,599 181,001 Finance lease liabilities (see note 6) 52,630 124,079 Other - 3,404 Total debt 263,229 308,484 Less: current portion 24,346 38,491 Total long-term debt 238,883 269,993 Scheduled maturities of long-term debt, including finance lease liabilities, are as follows: $ 2024 26,834 2025 29,199 2026 29,923 2027 17,958 2028 168,149 Total gross maturities 272,063 Less: imputed interest on finance lease liabilities (7,682 ) Less: debt issuance costs (1,152 ) Total debt 263,229 Credit Facilities On December 8, 2023, the Company entered into a new five-year Credit Agreement (the "New Credit Agreement") providing for (i) a $180.0 million term loan credit facility (the "New Term Loan Credit Facility") and (ii) an $85.0 million revolving credit facility (the "New Revolving Credit Facility" and together with the New Term Loan Credit Facility, the "New Credit Facilities"). The New Revolving Credit Facility includes $30.0 million of borrowing capacity available for letters of credit and provides for borrowings of up to $10.0 million on same-day notice including in the form of swingline loans. As at December 30, 2023, $5.9 million in letters of credit were issued but undrawn under the New Revolving Credit Facility. The New Credit Facilities terminate and replace the asset-based revolving and term loan credit obligations, commitments, liens and guaranties under the Company's Second Amended and Restated Credit Agreement, dated as of December 31, 2020 (as amended, the "2020 Credit Agreement"). The syndicate of lenders party to the New Credit Agreement is unchanged from the 2020 Credit Agreement. As at December 8, 2023, the Company used proceeds of $141.9 million from the New Credit Facilities to repay in full the amounts owing under 2020 Credit Agreement, and $56.0 million to repay and terminate certain finance lease obligations (see note 6). The Company incurred $2.2 million of debt issuance costs in connection with the New Credit Facilities, of which $1.2 million was allocated to the New Term Loan Credit Facility and recorded as a deduction to long-term debt, and $1.0 million was allocated to the New Revolving Credit Facility and recorded as deferred financing costs in other long-term assets. Capitalized debt issuance costs are being amortized to interest expense over the five-year term of the New Credit Agreement. In addition, the Company incurred a loss on extinguishment of debt of $1.6 million, which reflected $1.1 million of third-party costs incurred in connection with the New Term Loan Credit Facility, and the write-off of $0.5 million of unamortized deferred financing costs related to the 2020 Credit Agreement due to a reduction in the credit commitments under the New Revolving Credit Facility. The New Credit Facilities mature on December 8, 2028. Borrowings under the New Term Loan Credit Facility are repayable in quarterly principal installments of $2.3 million from the fiscal quarter ending March 31, 2024 to the fiscal quarter ending December 31, 2025, $3.4 million from the fiscal quarter ending March 31, 2026 to the fiscal quarter ending December 31, 2027, and $4.5 million from the fiscal quarter ending March 31, 2028 to the fiscal quarter ending September 30, 2028, with the remaining principal balance of $121.5 million due on the maturity date. Borrowings under the New Credit Facilities bear interest at a margin over various reference rates, including a base rate (as defined in the New Credit Agreement) and SOFR, selected at the option of the Company. The margin for the New Credit Facilities will be set quarterly based on the consolidated total net leverage ratio for the preceding fiscal quarter and will range from 1.00% to 2.25% with respect to base rate loans and from 2.00% to 3.25% for SOFR loans. Prior to the completion of the fiscal quarter ending March 31, 2024, the initial margins for the New Credit Facilities are 1.75% and 2.75% with respect to base rate and SOFR loans, respectively. As at December 30, 2023, the interest rate on outstanding borrowings under the New Credit Facilities was 8.22%. In addition, the Company is required to pay an undrawn fee under the New Revolving Credit Facility quarterly based on the consolidated total net leverage ratio for the preceding fiscal quarter ranging from 0.20% to 0.40% on the undrawn revolving commitments thereunder. The Company is also required to pay customary letter of credit fees, to the extent letters of credit are issued and outstanding under the New Revolving Credit Facility. All obligations under the New Credit Facilities are unconditionally guaranteed by the Company and substantially all of the Company's existing and future direct and indirect wholly-owned material restricted subsidiaries organized in the U.S. and Canada (the "Subsidiary Guarantors") and, subject to certain exceptions and qualifications, such obligations are secured by first priority security interest in substantially all of the tangible and intangible assets of the Company and Subsidiary Guarantors. The New Credit Facilities contain a number of covenants that, among other things, restrict, subject to certain exceptions, the Company's ability to: create liens on assets; sell assets and enter into sale and leaseback transactions; pay dividends, prepay contractually subordinated indebtedness and make other restricted payments; incur additional indebtedness and make guarantees; make investments, loans or advances, including acquisitions; engage in certain transactions with affiliates; fundamentally change the character of the Company's business; enter into contractual obligations that restrict the ability of the Company or any Subsidiary Guarantor to grant a lien on its assets in favor of the lenders and other secured creditors under the New Credit Facilities; and engage in mergers or consolidations. In addition, the Company is required to (i) maintain a minimum fixed charge coverage ratio of 1.20 to 1.00 as of the end of each quarterly test period and (ii) maintain a maximum consolidated total net leverage ratio of 4.00 to 1.00 for each quarterly test period prior to the fiscal quarter ending December 31, 2024, 3.75 to 1.00 for each quarterly test period from the fiscal quarter ending December 31, 2024 through the fiscal quarter ending September 30, 2025, and 3.50 to 1.00 for each quarterly test period for the fiscal quarter ending December 31, 2025 and thereafter; provided that, if the Company consummates an acquisition for consideration in excess of $50 million in any quarterly test period, then the maximum consolidated total net leverage ratio may, at the election of the Company (on no more than two occasions), be increased to the lesser of (x) 4.25 to 1.00 and (y) the then applicable maximum consolidated leverage ratio plus 0.50 to 1.00, for the end of the four succeeding quarterly test periods. The New Credit Facilities also contain certain customary affirmative covenants and events of default. As at December 30, 2023, the Company was in compliance with all covenants of the New Credit Agreement. Interest Expense, Net The components of interest expense, net are as follows: December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Interest expense, net of capitalized interest (see note 5) 24,422 11,889 6,462 Amortization of debt issuance costs 1,398 1,601 1,353 Loss on extinguishment of debt 1,584 - - Interest income (495 ) (334 ) (263 ) Interest expense, net 26,909 13,156 7,552

Series B-1 Preferred Stock

Series B-1 Preferred Stock	12 Months Ended
	Dec. 30, 2023
Class of Stock Disclosures [Abstract]
Series B-1 Preferred Stock [Text Block]	11. Series B-1 Preferred Stock On April 15, 2020, the Company and SunOpta Foods entered into a subscription agreement (the "Series B Subscription Agreement") with Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. (collectively, "Oaktree") and Engaged Capital, LLC, Engaged Capital Flagship Master Fund, LP and Engaged Capital Co-Invest IV-A, LP (collectively, "Engaged"). On April 24, 2020, pursuant to the Series B Subscription Agreement, SunOpta Foods issued 15,000 shares of Series B-1 Preferred Stock to each of Oaktree and Engaged for aggregate consideration of $30.0 million and 30,000 shares total (the "Series B-1 Preferred Stock"). Preferred dividends accrue daily on the Series B-1 preferred stock at an annualized rate of 8.0% of the liquidation preference prior to September 30, 2029, and 10.0% of the liquidation preference thereafter. For the second quarter of 2020, SunOpta Foods elected to pay dividends on the Series B-1 preferred stock in kind and, as a result, the aggregate liquidation preference increased to $30.4 million, or approximately $1,015 per share. On March 3, 2023, Engaged exercised their right to exchange all of their shares of Series B-1 Preferred Stock for 6,089,331 shares of the Company's common stock ("Common Shares") at an exchange price of $2.50, together with a cash payment to adjust for fractional Common Shares, plus accrued and unpaid dividends as of the date of exchange. The Common Shares exchanged represented approximately 5.3% of the Company's issued and outstanding Common Shares on a post-exchange basis. After the exchange, the exchanged shares of Series B-1 Preferred Stock previously held by Engaged were cancelled and SunOpta Foods is no longer required to pay dividends on those shares. Upon the exchange, the Company derecognized the $14.1 million carrying amount of the Series B-1 Preferred Stock previously held by Engaged, net of $1.1 million of unamortized issuance costs, and recognized a corresponding amount for the Common Shares issued on exchange, less common share issuance costs of $0.2 million. In connection with the exchange of the Series B-1 Preferred Stock, the Company redeemed all Special Shares, Series 2 of the Company that were held by Engaged. As at December 30, 2023, SunOpta Foods had 15,000 shares of Series B-1 Preferred Stock issued and outstanding to Oaktree. At any time, Oaktree may exchange the Series B-1 Preferred Stock, in whole or in part, into the number of Common Shares equal to, per share of Series B-1 Preferred Stock, the quotient of the liquidation preference divided by the exchange price of $2.50, while, at any time, SunOpta Foods may cause Oaktree to exchange all of their shares of Series B-1 Preferred Stock if the volume-weighted average price of the Common Shares during the then preceding 20 trading day period is greater than 200% of the exchange price then in effect. In addition, at any time on or after April 24, 2025, SunOpta Foods may redeem all of the Series B-1 Preferred Stock for an amount per share equal to the value of the liquidation preference at such time, plus accrued and unpaid dividends. On May 19, 2023, the Company issued 2,932,453 Special Shares, Series 2 to Oaktree. As a result of a permanent voting cap, the number of Special Shares, Series 2 issued to Oaktree at any time, when taken together with any other voting securities Oaktree then controls, cannot exceed 19.99% of the votes eligible to be cast by all security holders of the Company. In the first quarter of 2023, the Company paid cash dividends on the Series B-1 Preferred Stock of $0.6 million in the aggregate to Oaktree and Engaged related to the fourth quarter of 2022, together with a cash dividend $0.2 million paid to Engaged for the period from January 1, 2023 to March 3, 2023. In each of the second through fourth quarters of 2023, the Company paid a quarterly cash dividend of $0.3 million to Oaktree on the Series B-1 Preferred Stock, and, as at December 30, 2023, the Company accrued unpaid dividends to Oaktree of $0.3 million for the fourth quarter of 2023, which are recorded in accounts payable and accrued liabilities on the consolidated balance sheet. The carrying value of the Series B-1 Preferred Stock, net of unamortized issuance costs, is being accreted to the redemption value through charges to accumulated deficit, which amounted to $0.6 million for the year ended December 30, 2023 (December 31, 2022 - $0.7 million; January 1, 2022 - $0.5 million).

Common Shares

Common Shares	12 Months Ended
	Dec. 30, 2023
Equity [Abstract]
Common Shares [Text Block]	12. Common Shares The Company is authorized to issue an unlimited number of Common Shares without par value and an unlimited number of special shares without par value.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 30, 2023
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation [Text Block]	13. Stock-Based Compensation On May 28, 2013, the Company's shareholders approved the 2013 Stock Incentive Plan, as amended (the "2013 Plan"), which permits the grant of a variety of stock-based awards, including stock options, restricted stock units ("RSUs") and performance share units ("PSUs") to selected employees and directors of the Company. As at December 30, 2023, 3,619,054 securities remained available for issuance under the 2013 Plan. For the years ended December 30, 2023, December 31, 2022 and January 1, 2022, stock-based compensation of $11.8 million, $13.8 million and $9.1 million was recorded in selling, general and administrative expenses on the consolidated statements of operations. Stock Options Stock options granted to employees during the three-year period ended December 30, 2023, vest ratably on each of the first through third anniversaries of the grant date and expire on the tenth anniversary of the grant date. Stock options granted by the Company contain an exercise price that is equal to the closing market price of the shares on the day prior to the grant date. Any consideration paid on the exercise of stock options is credited to capital stock. The following table summarizes stock option activity for the year ended December 30, 2023: Weighted- average Weighted- remaining average contractual Aggregate Stock options exercise price term (years) intrinsic value Outstanding, beginning of year 3,920,600 $ 5.51 Granted 534,657 6.29 Exercised (310,167 ) 2.79 Forfeited (771,987 ) 6.53 Expired (25,000 ) 7.36 Outstanding, end of year 3,348,103 $ 5.63 6.5 $ 2,318 Exercisable, end of year 2,125,112 $ 5.33 5.2 $ 2,318 The total intrinsic value of stock options exercised during the year ended December 30, 2023 was $0.7 million. The following table summarizes non-vested stock option activity during the year ended December 30, 2023: Weighted- average grant- Stock options date fair value Non-vested, beginning of year 1,965,839 $ 3.63 Granted 534,657 3.87 Vested (786,033 ) 3.64 Forfeited (491,472 ) 3.79 Non-vested, end of year 1,222,991 $ 3.67 The weighted-average grant-date fair values of all stock options granted in the years ended December 30, 2023, December 31, 2022 and January 1, 2022, were $3.87, $3.49 and $8.10, respectively, using a Black-Scholes option pricing model with the following assumptions: December 30, 2023 December 31, 2022 January 1, 2022 Grant-date stock price $ 6.29 $ 5.91 $ 14.77 Dividend yield (a) 0% 0% 0% Expected volatility (b) 63.5% 61.6% 61.7% Risk-free interest rate (c) 4.1% 3.0% 1.0% Expected life of options (years) (d) 6.0 6.0 6.0 (a) Determined based on expected annual dividend yield at the time of grant. (b) Determined based on historical volatility of the Company's Common Shares over the expected life of the option. (c) Determined based on the yield on U.S. Treasury zero-coupon issues with maturity dates equal to the expected life of the option. (d) Determined based on the mid-point of vesting (one through three years) and expiration (10 years). The Company has used the simplified method to determine the expected life of options due to insufficient historical exercise data to provide a reasonable basis to estimate the expected life. Total compensation costs related to non-vested stock option awards not yet recognized as an expense was $2.0 million as at December 30, 2023, which will be amortized over a weighted-average remaining vesting period of 1.4 years. The following table summarizes stock options outstanding and exercisable as at December 30, 2023: Weighted- average remaining Weighted- Weighted- Exercise price range Outstanding contractual life average exercise Exercisable average exercise Low High options (years) price options price $ 3.25 $ 3.73 1,016,553 5.2 $ 3.35 1,016,553 $ 3.35 3.74 5.69 278,998 5.1 4.87 242,640 4.78 5.70 6.13 1,402,892 8.0 5.91 505,767 5.91 6.14 9.48 327,235 8.2 6.51 62,005 7.19 9.49 14.77 322,425 3.3 11.40 298,147 11.12 3,348,103 6.5 $ 5.63 2,125,112 $ 5.33 Restricted Stock Units RSUs granted to employees vest ratably on each of the first through third anniversaries of the grant date and RSUs granted to directors vest 100% on the first anniversary of the grant date. Each vested RSU entitles the employee or director to receive one Common Share without payment of additional consideration. The weighted-average grant-date fair values of all RSUs granted in the years ended December 30, 2023, December 31, 2022 and January 1, 2022, were $5.88, $6.40 and $13.54, respectively, based on the closing price of the Common Shares on the grant dates. The following table summarizes non-vested RSU activity during the year ended December 30, 2023: Weighted- average grant- RSUs date fair value Non-vested, beginning of year 659,649 $ 7.14 Granted 443,247 5.88 Vested (380,577 ) 6.57 Forfeited (122,595 ) 7.14 Non-vested, end of year 599,724 $ 6.58 The total intrinsic value of RSUs that vested during the year ended December 30, 2023 was $2.7 million. Total compensation costs related to non-vested RSU awards not yet recognized as an expense was $2.4 million as at December 30, 2023, which will be amortized over a weighted-average remaining vesting period of 1.8 years. Performance Share Units The vesting of PSUs granted to employees under the Company's annual short-term incentive plans are dependent on the Company achieving predetermined measures of adjusted earnings before interest, taxes, depreciation and amortization ("EBITDA") (the "EBITDA PSUs"). Each vested EBITDA PSU entitles the employee to receive one Common Share without payment of additional consideration. The weighted-average grant-date fair values of the EBITDA PSUs granted during the years ended December 30, 2023, December 31, 2022 and January 1, 2022, were $6.96, $5.45 and $13.90, respectively, based on the closing price of the Common Shares on the grant dates. The following table summarizes non-vested EBITDA PSU activity during the year ended December 30, 2023: Weighted- average grant- EBITDA PSUs date fair value Non-vested, beginning of year 2,355,431 $ 4.80 Granted 1,137,057 6.96 Vested (2,299,700 ) 4.78 Cancelled or forfeited (191,892 ) 6.55 Non-vested, end of year 1,000,896 $ 6.95 The total intrinsic value of EBITDA PSUs that vested during the year ended December 30, 2023 was $18.0 million. Each reporting period, the number of unvested EBITDA PSUs that are expected to vest is redetermined and the aggregate grant-date fair value of the redetermined number of EBITDA PSUs is amortized on a straight-line basis over the remaining requisite service period less amounts previously recognized. As at December 30, 2023, the compensation cost not yet recognized as an expense that are currently expected to vest was $2.3 million, which will be amortized over a weighted-average remaining vesting period of 0.3 years. The vesting of PSUs granted to employees under the Company's 2023, 2022 and 2021 long-term incentive plans ("LTIP") are dependent on the Company's total shareholder return ("TSR") performance relative to food and beverage companies in a designated index during a three-year performance period commencing on January 1 of the year of grant, and the employee's continued employment with the Company through the vesting date (the "TSR PSUs"). The TSR for the Company and each of the companies in the designated index are calculated at the end of the applicable three-year performance period using a 20-trading day average closing price as of December 31. The percentage of vested PSUs may range from 0% to 200% based on the Company's achievement of predetermined TSR thresholds. Each vested PSU entitles the employee to receive one Common Share without payment of additional consideration. None of the PSUs granted under the 2021 LTIP will vest as the Company did not achieve the minimum TSR threshold as measured at December 31, 2023. The grant-date fair values of TSR PSUs granted in the years ended December 30, 2023, December 31, 2022 and January 1, 2022, were $7.00, $8.48 and $23.40, respectively, using a Monte Carlo valuation model with the following assumptions: December 30, 2023 December 31, 2022 January 1, 2022 Grant-date stock price $ 6.35 $ 5.91 $ 14.77 Dividend yield 0% 0% 0% Expected volatility (a) 55.5% 67.8% 76.9% Risk-free interest rate (b) 4.7% 2.8% 0.3% Expected life (in years) (c) 2.5 2.7 2.7 (a) Determined based on the historical volatility of the Common Shares over the performance period of the PSUs. (b) Determined based on U.S. Treasury yields with a remaining term equal to the performance period of the PSUs. (c) Determined based on the performance period of the PSUs. The following table summarized non-vested TSR PSU activity during the year ended December 30, 2023: Weighted- average grant- TSR PSUs date fair value Non-vested, beginning of year 594,873 $ 10.07 Granted 405,212 7.00 Vested - - Forfeited (443,405 ) 8.61 Non-vested, end of year 556,680 $ 9.00 Total compensation costs related to non-vested TSR PSU awards not yet recognized as an expense was $2.5 million as at December 30, 2023, which will be amortized over a weighted-average remaining vesting period of 1.8 years. Special Awards On January 2, 2024, the Company granted special one-time awards of 144,404 RSUs, 288,808 TSR PSUs and 230,804 stock options to Brian Kocher in connection with his appointment as the Company's Chief Executive Officer effective January 2, 2024. These awards represent sign-on inducement awards made outside of 2013 Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the grant date, and each vested RSU entitles Mr. Kocher to receive one Common Share without payment of additional consideration. The vesting of the PSUs is dependent on the Company's TSR performance relative to food and beverage companies in a designated index during the three-year period commencing January 1, 2024 and continuing through December 31, 2026, and subject to Mr. Kocher's continued employment with the Company through April 15, 2027. The TSR for the Company and each of the companies in the designated index will be calculated using a 20-trading day average closing price as of December 31, 2026. The percentage of vested PSUs may range from 0% to 200% based on the Company's achievement of predetermined TSR thresholds. Each vested PSU entitles Mr. Kocher to receive one Common Share without payment of additional consideration. The stock options vest ratably on each of the first through third anniversaries of the grant date and expire on the tenth anniversary of the grant date. Each vested stock option entitles Mr. Kocher to purchase one Common Share at an exercise price of $5.54, which was the closing price of the Common Shares on January 2, 2024. Employee Stock Purchase Plan The Company maintains an Employee Stock Purchase Plan whereby employees can purchase common shares through payroll deductions. For the year ended December 30, 2023, the Company's employees purchased 120,666 Common Shares (December 31, 2022 - 87,850; January 1, 2022 - 66,834) for total proceeds of $0.6 million (December 31, 2022 - $0.6 million; January 1, 2022 - $0.6 million). As at December 30, 2023, 425,566 Common Shares remained available to be granted under this plan.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes [Text Block]	14. Income Taxes The income tax expense (benefit) differs from the amount that would have resulted from applying the combined Canadian federal and provincial statutory income tax rate to earnings (loss) from continuing operations before income taxes due to the following: December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Earnings (loss) from continuing operations before income taxes (18,641 ) 4,777 689 Canadian statutory rate 26.5% 26.5% 26.5% Income tax expense (benefit) at statutory rate (4,940 ) 1,266 183 Stock-based compensation (778 ) 1,054 (4,714 ) Change in valuation allowance 5,911 (471 ) 975 Disallowed executive compensation 2,372 367 135 Foreign tax rate differential 107 (156 ) (73 ) Change in enacted tax rates 90 (9 ) 17 Other 507 (1,155 ) (1,377 ) Income tax expense (benefit) 3,269 896 (4,854 ) The components of earnings (loss) from continuing operations before income taxes are shown below: December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Canada (9,202 ) (11,455 ) (10,522 ) U.S. (9,439 ) 16,232 11,211 Earnings (loss) from continuing operations before income taxes (18,641 ) 4,777 689 The components of income tax expense (benefit) are shown below: December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Current income tax expense (benefit): Canada (32 ) 84 (9 ) U.S. (677 ) 1,108 (283 ) (709 ) 1,192 (292 ) Deferred income tax expense (benefit): Canada - - 299 U.S. 3,978 (296 ) (4,861 ) 3,978 (296 ) (4,562 ) Income tax expense (benefit) 3,269 896 (4,854 ) Deferred income taxes of the Company are comprised of the following: December 30, 2023 December 31, 2022 $ $ Loss and credit carryovers 43,871 20,201 Lease liabilities 29,395 23,609 Interest expense limitation (163j) 15,906 9,464 Inventory basis differences 3,723 1,805 Stock-based compensation 1,255 2,160 Right-of-use lease assets (28,285 ) (23,071 ) Property, plant and equipment and intangible assets (18,537 ) (28,088 ) Other 2,623 2,458 49,951 8,538 Less: valuation allowance 50,456 4,826 Deferred income tax asset (liability) (505 ) 3,712 The components of the deferred income tax asset (liability) are shown below: December 30, 2023 December 31, 2022 $ $ Canada (325 ) (325 ) U.S. - 3,978 Other (180 ) 59 Deferred income tax asset (liability) (505 ) 3,712 The components of the deferred income tax valuation allowance are as follows: December 30, 2023 December 31, 2022 $ $ Balance, beginning of year 4,826 5,267 Increase (decrease) in valuation allowance 45,630 (441 ) Balance, end of year 50,456 4,826 The following table details the Company's tax attributes as at December 30, 2023, primarily related to net operating losses, tax credits and capital losses for which it has recorded deferred tax assets: Gross attribute amount Net attribute amount Expiration years Tax Attributes Net operating losses - Canada $ 2,123 $ 563 2040-2041 Net operating losses - U.S. Federal 145,989 30,658 2037 and indefinite Net operating losses - U.S. State 103,009 5,613 2027-2043 and indefinite Net operating losses - Other 167 50 2028 Federal credits - Canada - 255 N/A Federal credits - U.S. - 2,833 2031-2043 State credits - U.S. - 211 2024-2026 Federal capital loss - Canada 27,838 3,688 N/A Total $ 43,871 The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized. In making such determinations, the Company considers all available positive and negative evidence, including future reversals of existing temporary differences, projected future taxable income, tax planning strategies and recent financial operations. Based on this evaluation, as at December 30, 2023, a valuation allowance of $50.5 million (December 31, 2022 - $4.8 million) had been recorded against certain assets to reduce the net benefit recorded in the consolidated financial statements. As the undistributed earnings of the Company's non-Canadian affiliates and associated companies are considered to be indefinitely reinvested, no provision for deferred taxes has been provided thereon. For the years ended December 30, 2023, December 31, 2022 and January 1, 2022, the Company did not identify any material uncertain tax positions or recognize any related tax benefits. The Company believes it has adequately examined its tax positions taken or expected to be taken in a tax return; however, amounts asserted by taxing authorities could differ from the Company's positions. Accordingly, additional provisions on federal, provincial, state and foreign tax-related matters could be recorded in the future as revised estimates are made or the underlying matters are settled or otherwise resolved. Consistent with its historical financial reporting, the Company has classified interest and penalties related to income tax liabilities, when applicable, as part of interest expense in its consolidated statements of operations, and with the related liability on the consolidated balance sheets. The number of years with open tax audits varies depending on the tax jurisdiction. The Company's major taxing jurisdictions are the U.S. (including multiple states) and Canada (Ontario). The Company's 2019 through 2022 tax years (and any tax year for which available non-capital loss carryforwards were generated up to the amount of non-capital loss carryforward) remain subject to examination by the Internal Revenue Service for U.S. federal tax purposes, and tax years 2016 through 2022 remain subject to examination by the appropriate governmental agencies for Canadian federal tax purposes. There are other ongoing audits in various other jurisdictions that are not considered material to the Company's consolidated financial statements.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	12 Months Ended
	Dec. 30, 2023
Earnings (Loss) Per Share [Abstract]
Earnings (Loss) Per Share [Text Block]	15. Earnings (Loss) Per Share Basic and diluted earnings (loss) per share were calculated as follows (shares in thousands): December 30, 2023 December 31, 2022 January 1, 2022 Numerator Earnings (loss) from continuing operations $ (21,910 ) $ 3,881 $ 5,543 Less: dividends and accretion on preferred stock (1,981 ) (3,109 ) (4,197 ) Earnings (loss) from continuing operations attributable to common shareholders (23,891 ) 772 1,346 Loss from discontinued operations (153,108 ) (8,722 ) (6,715 ) Loss attributable to common shareholders $ (176,999 ) $ (7,950 ) $ (5,369 ) Denominator Basic weighted-average number of shares outstanding 114,226 107,659 104,098 Dilutive effect of the following: Stock options and restricted stock units (1) - 2,588 2,889 Series B-1 Preferred Stock (2) - - - Diluted weighted-average number of shares outstanding 114,226 110,247 106,987 Basic Earnings (Loss) Per Share Earnings (loss) from continuing operations $ (0.21 ) $ 0.01 $ 0.01 Loss from discontinued operations (1.34 ) (0.08 ) (0.06 ) Loss attributable to common shareholders $ (1.55 ) $ (0.07 ) $ (0.05 ) Diluted Earnings (Loss) Per Share Earnings (loss) from continuing operations $ (0.21 ) $ 0.01 $ 0.01 Loss from discontinued operations (1.34 ) (0.08 ) (0.06 ) Loss attributable to common shareholders $ (1.55 ) $ (0.07 ) $ (0.05 ) (1) (2)

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	12 Months Ended
	Dec. 30, 2023
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information [Text Block]	16. Supplemental Cash Flow Information December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Changes in Operating Assets and Liabilities, Net of Divestitures Accounts receivable (4,034 ) (4,948 ) (5,893 ) Inventories (8,776 ) (10,300 ) (17,780 ) Accounts payable and accrued liabilities (4,805 ) (4,246 ) 23,499 Other operating assets and liabilities (7,384 ) 4,352 3,382 (24,999 ) (15,142 ) 3,208 Non-Cash Investing and Financing Activities Change in additions to property, plant and equipment included in accounts payable and accrued liabilities (436 ) (4,234 ) 3,638 Change in accrued dividends on preferred stock (305 ) - (1,769 ) Estimated net working capital adjustment related to the divestiture of Frozen Fruit (see note 2) (457 ) - - Change in short-term note receivable from divestiture of Frozen Fruit (see note 2) (6,300 ) - - Seller Promissory Notes issued on the divestiture of Frozen Fruit (see note 2) (20,000 ) - - Paid in kind interest on Seller Promissory Notes (300 ) - - Change in proceeds receivable from Sunflower divestiture (1) 385 (385 ) - Change in accrued transaction costs related to the divestiture of Tradin Organic (2) - - (13,380 ) Change in accrued debt issuance costs - - (1,690 ) Cash Paid Interest 24,032 11,093 5,520 Income taxes 569 847 3,632 (1) (2)

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies [Text Block]	17. Commitments and Contingencies Legal Proceedings Various current and potential claims and litigation arising in the ordinary course of business are pending against the Company. The Company believes it has established adequate accruals for liabilities that are probable and reasonably estimable that may be incurred in connection with any such currently pending matter. In the Company's opinion, the eventual resolution of such matters, either individually or in the aggregate, is not expected to have a material impact on the Company's financial position, results of operations, or cash flows. However, litigation is inherently unpredictable and resolutions or dispositions of claims or lawsuits by settlement or otherwise could have an adverse impact on the Company's financial position, results of operations, and cash flows for the reporting period in which any such resolution or disposition occurs. Product Recall On June 21, 2023, the Company announced its subsidiary, Sunrise Growers Inc., had issued a voluntary recall of specific frozen fruit products linked to pineapple provided by a third-party supplier due to possible contamination by Listeria monocytogenes. Sunrise Growers Inc. is a component of the operations of Frozen Fruit. For the year ended December 30, 2023, the Company recognized charges of $0.9 million for customer returns of the recalled products, $3.0 million for inventory on-hand at the time of the recall, and $3.4 million for the reimbursement of customer lost profits and consumer refunds and claims for damages related to the recall. The Company is seeking to recover a portion of the recall-related costs through its insurance coverage, and such recoveries are recorded in the period in which the recoveries are determined to be probable of realization. For the year ended December 30, 2023, the Company recognized estimated insurance recoveries, net of deductibles, of $4.8 million. In connection with the divestiture of Frozen Fruit, the recall-related costs and estimated insurance recoveries are included in the loss from discontinued operations in the consolidated statement of operations for the year ended December 30, 2023. As at December 30, 2023, estimated insurance recoveries of $4.8 million are included in prepaid expenses and other current assets, and $1.3 million of recall-related costs are included in accounts payable and accrued liabilities on the consolidated balance sheet. The Company expects to incur additional costs related to the recall during the first quarter of 2024, including product warehousing, transportation and destruction costs, as well as administrative costs. The Company expects that these additional costs will be generally covered under its insurance policies; however, as of the date of this filing, the Company cannot be certain of its ability to recover recall-related costs through its insurance coverage or the extent of any such recovery. Environmental Laws The Company believes that, with respect to both its operations and real property, it is in material compliance with current environmental laws. Based on known existing conditions and the Company's experience in complying with emerging environmental issues, the Company is of the view that future costs relating to environmental compliance will not have a material adverse effect on its consolidated financial position, but there can be no assurance that unforeseen changes in the laws or enforcement policies of relevant governmental bodies, the discovery of changed conditions on the Company's real property or in its operations, or changes in the use of such properties and any related site restoration requirements, will not result in the incurrence of significant costs.

Disaggregation of Revenue, Geog

Disaggregation of Revenue, Geographic Information, and Major Customers	12 Months Ended
	Dec. 30, 2023
Segment Reporting [Abstract]
Disaggregation of Revenue, Geographic Information, and Major Customers [Text Block]	18. Disaggregation of Revenue, Geographic Information, and Major Customers Disaggregation of Revenue The principal products that comprise the Company's product categories are as follows: Category Principal Products Beverages and broths Plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases, including Dream ® ® Fruit snacks Ready-to-eat fruit snacks made from apple purée Ingredients Liquid and powder ingredients utilizing oat, soy and hemp bases. Smoothie bowls Ready-to-eat fruit smoothie and chia bowls topped with frozen fruit. Revenue disaggregated by product category is as follows: December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Product Category Beverages and broths (1) 502,793 454,446 372,398 Fruit Snacks 98,186 82,869 62,742 Ingredients (1), (2) 17,032 45,366 61,315 Smoothie bowls (3) 12,286 8,714 - Total revenues 630,297 591,395 496,455 (1) For the year ended December 30, 2023, the Company reclassified certain product sales that were previously recorded in Beverages and Broths to Ingredients to better reflect the nature of the product offerings. The comparative figures for the years ended December 31, 2022 and January 1, 2022 have been conformed to the current year presentation. (2) For the year ended January 1, 2022, ingredient revenues include $26.1 million from the production and sale of fruit-based ingredients for industrial use prior to the Company's rationalization of the product line in July 2021. (3) As described in note 19, on February 23, 2024, the Company entered into an agreement to sell the assets related to its smoothie bowl product line. Geographic Information Revenues from external customers are attributed to countries based on the location of the customer. Revenues from external customers by geographic area for the years ended December 30, 2023, December 31, 2022 and January 1, 2022 were as follows: December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Revenues from External Customers U.S. 615,133 577,515 483,544 Canada 11,740 8,973 9,319 Other 3,424 4,907 3,592 Total revenues from external customers 630,297 591,395 496,455 Long-lived assets consist of property, plant and equipment, net of accumulated depreciation, which are attributed to countries based on the physical location of the assets. Long-lived assets by geographic area as at December 30, 2023 and December 31, 2022 were as follows: December 30, 2023 December 31, 2022 $ $ Long-Lived Assets U.S. 317,830 290,266 Canada 2,068 2,040 Total long-lived assets 319,898 292,306 Major Customers Customers accounting for more than 10% of the Company's consolidated revenues from continuing operations in any of the past three fiscal years were as follows: December 30, 2023 December 31, 2022 January 1, 2022 Customer A 34% 31% 30% Customer B 8% 14% 13%

Subsequent Event

Subsequent Event	12 Months Ended
	Dec. 30, 2023
Subsequent Events Abstract
Subsequent Event [Text Block]	19. Subsequent Event Sale of Assets On February 23, 2024, the Company entered into an agreement to sell the assets related to its smoothie bowl product line for proceeds of approximately $6.0 million. The transaction is expected to close on March 4, 2024. The sale of the smoothie bowl product line will be reported in continuing operations in the first quarter of 2024.

Quarterly Results of Operations

Quarterly Results of Operations (unaudited)	12 Months Ended
	Dec. 30, 2023
Quarterly Financial Information Disclosure [Abstract]
Quarterly Results of Operations (unaudited) [Text Block]	20. Quarterly Results of Operations (unaudited) The following table presents the unaudited consolidated results of operations of the Company for each of the quarters in the years ended Fiscal 2023 First Second Third Fourth Quarter Quarter Quarter Quarter $ $ $ $ Revenues 154,969 141,163 152,541 181,624 Gross profit 24,079 18,629 20,268 25,641 Loss from continuing operations (2,827 ) (11,651 ) (5,680 ) (1,752 ) Earnings (loss) from discontinued operations 4,204 (7,187 ) (140,143 ) (9,982 ) Net earnings (loss) 1,377 (18,838 ) (145,823 ) (11,734 ) Dividends and accretion of preferred stock (704 ) (422 ) (426 ) (429 ) Earnings (loss) attributable to common shareholders 673 (19,260 ) (146,249 ) (12,163 ) Basic and diluted earnings (loss) per share: Loss from continuing operations (0.03 ) (0.10 ) (0.05 ) (0.02 ) Earnings (loss) from discontinued operations 0.04 (0.06 ) (1.21 ) (0.09 ) Earnings (loss) attributable to common shareholders (1) 0.01 (0.17 ) (1.26 ) (0.11 ) Fiscal 2022 First Second Third Fourth Quarter Quarter Quarter Quarter $ $ $ $ Revenues 139,517 148,065 144,023 159,790 Gross profit 23,769 27,013 25,132 23,816 Earnings (loss) from continuing operations 1,021 928 2,359 (427 ) Earnings (loss) from discontinued operations 3,547 543 (14,293 ) 1,481 Net earnings (loss) 4,568 1,471 (11,934 ) 1,054 Dividends and accretion of preferred stock (755 ) (760 ) (764 ) (830 ) Earnings (loss) attributable to common shareholders 3,813 711 (12,698 ) 224 Basic and diluted earnings (loss) per share: Earnings from continuing operations 0.00 0.00 0.01 (0.01 ) Earnings (loss) from discontinued operations 0.03 0.01 (0.13 ) 0.01 Earnings (loss) attributable to common shareholders (1) 0.04 0.01 (0.12 ) 0.00 (1)

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 30, 2023	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ (11,734)	$ (145,823)	$ (18,838)	$ 1,377	$ 1,054	$ (11,934)	$ 1,471	$ 4,568	$ (175,018)	$ (4,841)	$ (1,172)

Insider Trading Arrangements

Insider Trading Arrangements	12 Months Ended
	Dec. 30, 2023
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	During the quarter ended December 30, 2023, none of our directors or officers adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement.
Title	directors or officers
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Terminated	false

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation [Policy Text Block]	Basis of Presentation These consolidated financial statements include the accounts of SunOpta Inc. and those of its wholly-owned subsidiaries (collectively, the "Company" or "SunOpta") and have been prepared by the Company in United States ("U.S.") dollars and in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). All intercompany accounts and transactions have been eliminated on consolidation.
Fiscal Year [Policy Text Block]	Fiscal Year The fiscal year of the Company consists of a 52- or 53-week period ending on the Saturday closest to December 31. Fiscal years 2023, 2022 and 2021 were each 52-week periods ending on December 30, 2023, December 31, 2022 and January 1, 2022, respectively. Fiscal year 2024 will be a 52-week period ending on December 28, 2024, with quarterly periods ending on March 30, 2024, June 29, 2024, and September 28, 2024.
Discontinued Operations [Policy Text Block]	Discontinued Operations As described in note 2, on October 12, 2023, the Company completed the divestiture of its frozen fruit business ("Frozen Fruit"). The divestiture of Frozen Fruit completes the Company's strategic optimization plan for its non-core, commodity-based businesses, which included the divestiture of its sunflower business ("Sunflower") in October 2022, in order to focus on value-add products in plant-based and healthy snack categories. Beginning in the third quarter of 2023, Frozen Fruit and Sunflower met the criteria for reporting as discontinued operations, and, as such, the operating results and cash flows of Frozen Fruit and Sunflower for the years ended December 31, 2022 and January 1, 2022 have been reclassified to discontinued operations on the consolidated statements of operations and cash flows, and the assets and liabilities of the Frozen Fruit disposal group have been reclassified and reported as held for sale on the consolidated balance sheet as at December 31, 2022. In addition, the information disclosed in these notes to the consolidated financial statements is presented on a continuing operations basis, with comparative period information recast to reflect Frozen Fruit and Sunflower as discontinued operations.
Segment Information [Policy Text Block]	Segment Information In connection with the divestiture of Frozen Fruit, the Company changed its internal organization and reporting structures beginning in the third quarter of 2023 and began operating as one segment. These changes included the elimination of the roles and responsibilities of the former General Managers of the Company, who were previously identified as the segment managers of the Company's former Plant-Based and Fruit-Based Foods and Beverages operating and reportable segments. With these changes, the Company's Chief Executive Officer, who has been identified as the Chief Operating Decision Maker ("CODM"), manages operations on a company-wide basis, rather than at a product category or business unit level. The CODM is supported by a centralized management team based on functional area, including sales, marketing, supply chain, and research and development, as well as finance, IT and administration. Only the CODM has overall responsibility and accountability for the profitability and cash flows of the Company. Using financial information at the consolidated level, the CODM makes key operating decisions, including approving annual operating plans, expanding into new markets or product categories, pursuing business acquisitions or divestitures, and initiating major capital expenditure programs. In addition, the CODM determines the allocation of resources and capital investments to optimize operations and maximize opportunities for the Company as a whole, without regard to specific product categories or business units. The CODM also uses consolidated information to assess performance against the annual operating plan and to set company-wide incentive compensation targets. Following the divestiture of its commodity-based businesses, the majority of the Company's products are shelf-stable packaged food and beverage products and share similar customers and distribution. Refer to note 18 for a disaggregation of the Company's revenues by product category.
Use of Estimates [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Areas involving significant estimates and assumptions include: allowances for credit losses; inventory reserves; income tax liabilities and assets, and related valuation allowances; provisions for loss contingencies related to claims and litigation; useful lives of property, plant and equipment and intangible assets; expected lease terms and discount rates in measuring lease assets and liabilities; expected future cash flows used in evaluating long-lived assets for impairment; and reporting unit fair values in testing goodwill for impairment. The estimates and assumptions made require judgment on the part of management and are based on the Company's historical experience and various other factors that are believed to be reasonable in the circumstances. Management continually evaluates the information that forms the basis of its estimates and assumptions as the business of the Company and the general business environment changes.
Fair Value [Policy Text Block]	Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (that is, an exit price). Fair value measurements are estimated based on inputs categorized as follows: Level 1 inputs include quoted prices (unadjusted) for identical assets or liabilities in active markets that are observable. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 includes unobservable inputs that reflect the Company's own assumptions about what factors market participants would use in pricing the asset or liability. When measuring fair value, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs.
Foreign Currency Transactions [Policy Text Block]	Foreign Currency Transactions Gains or losses resulting from transactions denominated in foreign currencies are included in foreign exchange gain/loss on the consolidated statements of operations.
Cash and Cash Equivalents [Policy Text Block]	Cash and Cash Equivalents Cash and cash equivalents consist of cash and short-term deposits with an original maturity of 90 days or less. The Company places its cash and cash equivalents with institutions of high creditworthiness.
Restricted Cash [Policy Text Block]	Restricted Cash Restricted cash consists of cash that is legally restricted as to withdrawal or usage.
Accounts Receivable [Policy Text Block]	Accounts Receivable Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The allowance for credit losses is an estimate of the amount of probable losses in existing accounts receivable. The Company routinely assesses the financial strength of its customers and believes that its accounts receivable credit risk exposure is limited. The Company closely monitors receivable balances and estimates an allowance for credit losses based on historical collection experience, and account aging analysis and trends, and evaluates the adequacy of the allowance each reporting period, considering individual customer account reviews, write-offs recorded in the period, sales forecasts and trends, and current and expected economic and customer-specific conditions. Account balances are charged off against the allowance when the Company determines the receivable will not be recovered. As at December 30, 2023, two long-term customers represented approximately 33% and 14%, respectively, of the Company's consolidated accounts receivable balance. The Company does not believe it is exposed to any significant credit risks with respect to these customers.
Inventories [Policy Text Block]	Inventories Inventories are valued at the lower of cost and net realizable value on a first-in, first-out basis. Shipping and handling costs are included in cost of goods sold on the consolidated statements of operations.
Property, Plant and Equipment [Policy Text Block]	Property, Plant and Equipment Property, plant and equipment assets are stated at cost, less accumulated depreciation. Cost includes capitalized interest on borrowings during the construction of major capital projects. Depreciation begins when an asset is ready for its intended use. Property, plant and equipment assets, other than land, are depreciated on a straight-line basis over the estimated useful lives of the assets, as follows: Buildings 20 - 40 years Machinery and equipment 5 - 20 years Enterprise software 3 - 5 years Office furniture and equipment 3 - 7 years Vehicles 3 - 7 years
Leases [Policy Text Block]	Leases At the lease commencement date, the Company recognizes a right-of-use lease asset for an amount equal to the lease liability, less any lease incentives. The lease liability is determined based on the present value of future lease payments over the lease term. The lease term includes the noncancellable term of the lease, together with periods covered by options to extend the lease that the Company is reasonably certain to exercise. The discount rate used to determine the present value of the future lease payments is the implicit rate in the lease if readily determinable. When that rate is not readily determinable, the Company applies its incremental borrowing rate, which its estimated using relevant interest rate yield curves and credit spreads derived from available market data. The Company excludes material non-lease components in determining the future lease payments. Material leases with an initial term of 12 months or less are recorded on the balance sheet.
Intangible Assets [Policy Text Block]	Intangible Assets The Company's finite-lived intangible assets consist of brand names and customer relationships. Intangible assets are amortized on a straight-line basis over their estimated useful lives, which are 15 years for brand names and 20 years for customer relationships.
Impairment of Long-Lived Assets [Policy Text Block]	Impairment of Long-Lived Assets The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If the carrying amount of an asset is not recoverable, the fair value of the asset is determined typically using an income approach (discounted cash flow analysis). An impairment loss is recognized in earnings for any excess of the carrying amount of the asset over its fair value.
Goodwill [Policy Text Block]	Goodwill Goodwill represents the excess in a business combination of the purchase price over the estimated fair value of the identifiable net assets acquired. Goodwill is not amortized but is instead tested for impairment at the reporting unit level at least annually, or whenever events or circumstances change between the annual impairment tests that would indicate the carrying amount of goodwill may be impaired. The Company performs its annual test for goodwill impairment in the fourth quarter of each fiscal year. The Company can elect to qualitatively assess goodwill for impairment if it is more likely than not that the fair value of a reporting unit exceeds its carrying value. If the Company elects to quantitatively assess goodwill, or it is not more likely than not that the fair value of a reporting unit exceeds its carrying value, the Company estimates the fair value of each of its reporting units using an income approach (discounted cash flow method). Goodwill impairment charges are recognized based on the excess of a reporting unit's carrying amount over its fair value. Based on Company's qualitative assessment, it was determined that goodwill was not impaired as at December 30, 2023.
Debt Issuance Costs [Policy Text Block]	Debt Issuance Costs Costs incurred in connection with obtaining debt financing are deferred and amortized over the term of the financing arrangement. Costs incurred to secure revolving credit facilities are recorded in other long-term assets. All other debt issuance costs are recorded as a direct deduction from the related debt liability.
Income Taxes [Policy Text Block]	Income Taxes The Company follows the asset and liability method of accounting for income taxes whereby deferred income tax assets are recognized for deductible temporary differences and operating loss carryforwards, and deferred income tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the amounts of assets and liabilities recorded for income tax and financial reporting purposes. Deferred income tax assets are recognized only to the extent that management determines that it is more likely than not that the deferred income tax assets will be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The income tax expense or benefit is the income tax payable or recoverable for the year plus or minus the change in deferred income tax assets and liabilities during the year. The Company is subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, the Company may incur additional income tax expense based upon the outcomes of such matters. In addition, when applicable, the Company adjusts income tax expense to reflect the Company's ongoing assessments of such matters, which requires judgment and can materially increase or decrease its effective rate as well as impact operating results. The evaluation of tax positions taken or expected to be taken in a tax return is a two-step process, whereby (i) the Company determines whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and (ii) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the related tax authority.
Stock Incentive Plan [Policy Text Block]	Stock Incentive Plan The Company maintains a stock incentive plan under which stock options and other stock-based awards may be granted to selected employees and directors. The Company measures stock-based awards at fair value as of the date of grant. Compensation expense is recognized on a straight-line basis over vesting period of the entire stock-based award, based on the number of awards that ultimately vest. Upon exercise, stock-based awards are settled through the issuance of common shares and are therefore treated as equity awards.
Revenue Recognition [Policy Text Block]	Revenue Recognition The Company manufactures and sells food and beverage products to retailers, foodservice operators, branded food companies, and other food manufacturers. The Company recognizes revenue when performance obligations under the terms of a contract with a customer are satisfied, which is upon the transfer of control of the contracted goods. Except for goods sold under bill-and-hold arrangements, control is transferred when title and physical possession of the product transfers to the customer, which is at the point in time that product is shipped from the Company's facilities or delivered to a specified destination, depending on the terms of the contract, and the Company has a present right to payment. Under bill-and-hold arrangements, whereby the Company bills a customer for product to be delivered at a later date, control typically transfers when the product is ready for physical transfer to the customer, and the Company has a present right to payment. A performance obligation is a promise within a contract to transfer distinct goods to the customer. A contract with a customer may involve multiple products and/or multiple delivery dates, with the transfer of each product at each delivery date being considered a distinct performance obligation, as each of the Company's products has standalone utility to the customer. In these cases, the contract's transaction price is allocated to each performance obligation based on relative standalone selling prices and recognized as revenue when each individual product is transferred to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods. Consideration is typically determined based on a fixed unit price for the quantity of product transferred. Certain contracts include rebates and other forms of variable consideration. For contracts involving variable consideration, the Company estimates the transaction price based on the amount of consideration to which it expects to be entitled. These estimates are determined based on historical experience and the expected outcome of the variable consideration, and are updated as new information becomes available, including actual claims paid, which indicate an estimate is not indicative of the expected results. Changes to these estimates are recorded in the period the adjustment is identified. The Company does not typically grant customers a general right of return for goods transferred but will generally accept returns of product for quality-related issues. The cost of satisfying this promise of quality is accounted for as an assurance-type warranty obligation rather than variable consideration. The Company's contracts do not typically include any significant payment terms, as payment is normally due shortly after the time of transfer. Revenue contracts are typically represented by short-term, binding purchase orders from customers, identifying the quantity and pricing for products to be transferred. Customer purchase orders may be issued under long-term master supply arrangements. On their own, these master supply arrangements are typically not considered contracts for purposes of revenue recognition, as they do not create enforceable rights and obligations regarding the quantity, pricing, or timing of goods to be transferred; however, certain master supply agreements impose minimum purchase obligations on the part of the customers, which is considered a form of variable consideration. Other master supply arrangements provide for the transfer of product on a bill-and-hold basis at the specific request of the customer. As goods are produced under these bill-and-hold arrangements to meet individual customer specifications, they are identifiable as belonging to the customer and cannot be directed to another customer. The timing of the Company's revenue recognition, customer billings and cash collections, does not result in significant unbilled receivables (contract assets) or customer advances (contract liabilities) on the consolidated balance sheet. Contract costs, such as sales commissions, are generally expensed as incurred given the short-term nature of the associated contracts.
Advertising Costs [Policy Text Block]	Advertising Costs Advertising costs are expensed as incurred and are included in selling, general and administrative expenses.
Research and Development Costs [Policy Text Block]	Research and Development Costs Research and development costs are expensed as incurred and are included in selling, general and administrative expenses. The Company's research and development activities are directed towards custom product formulations, packaging innovations, and production process improvements. The Company's research and development expenditures primarily consist of employee-related compensation and supplies, as well as rental costs and depreciation expense related to the Company's innovation center and pilot plant.
Earnings Per Share [Policy Text Block]	Earnings Per Share Basic earnings per share is computed by dividing earnings available to common shareholders by the weighted-average number of common shares outstanding during the year. Earnings attributable to common shareholders is computed by deducting dividends and accretion on convertible preferred stock from net earnings. The potential diluted effect of stock options and other stock-based awards is computed using the treasury stock method whereby the weighted-average number of common shares used in the basic earnings per share calculation is increased to include the number of additional common shares that would have been outstanding if the potential dilutive common shares had been issued at the beginning of the year. The potential dilutive effect of convertible preferred stock is computed using the if-converted method whereby dividends and accretion on the convertible preferred stock are added back to the numerator, and the common shares resulting from the assumed conversion of the convertible preferred stock are included in the denominator of the diluted earnings per share calculation.
Contingencies [Policy Text Block]	Contingencies In the normal course of business, the Company is subject to loss contingencies, such as accrued but unpaid bonuses, tax-related matters, product recall-related claims and recoveries, and other claims or litigation. Accruals for loss contingencies are recorded when the Company determines that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. If the estimate of the amount of the loss is a range and some amount within the range appears to be a better estimate than any other amount within the range, that amount is accrued as a liability. If no amount within the range is a better estimate than any other amount, the minimum amount of the range is accrued as a liability.
Recent Accounting Pronouncements [Policy Text Block]	Recent Accounting Pronouncements In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Useful Life for Property Plant and Equipment [Table Text Block]	Buildings 20 - 40 years Machinery and equipment 5 - 20 years Enterprise software 3 - 5 years Office furniture and equipment 3 - 7 years Vehicles 3 - 7 years

Discontinued Operations (Tables

Discontinued Operations (Tables) - Divestiture of Frozen Fruit [Member]	12 Months Ended
	Dec. 30, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Schedule of Discontinued Operations to Amounts Reported in the Consolidated Statements of Operations [Table Text Block]	December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Revenues 200,029 343,267 316,169 Cost of goods sold (1) 211,467 320,143 299,593 Selling, general and administrative expenses (2) 8,683 10,843 11,821 Intangible asset amortization 6,000 8,498 8,664 Other expense (income), net (3) 10,112 (2,746 ) 2,145 Foreign exchange loss (gain) (3,333 ) (1,641 ) 1,018 Interest expense, net (4) 554 1,578 1,217 Earnings (loss) before loss on divestiture (33,454 ) 6,592 (8,289 ) Pre-tax loss on divestiture (5) (119,821 ) (31,468 ) - Loss from discontinued operations before income taxes (153,275 ) (24,876 ) (8,289 ) Income tax benefit (6) (167 ) (16,154 ) (1,574 ) Loss from discontinued operations (153,108 ) (8,722 ) (6,715 ) (1) (2) (3) (4) (5) (6)
Schedule of Major Classes of Assets and Liabilities of Discontinued Operations [Table Text Block]	December 30, 2023 December 31, 2022 $ $ Assets Accounts receivable - 15,358 Inventories (1) 5,910 132,608 Other current assets - 153 Property, plant and equipment, net - 30,085 Operating lease right-of-use assets - 3,803 Intangible assets, net - 112,000 Total assets held for sale 5,910 294,007 Liabilities Accounts payable and accrued liabilities - 12,632 Operating lease liabilities - 3,803 Total liabilities held for sale - 16,435 (1) As at December 30, 2023, inventories held for sale reflect the remaining carrying value of the frozen fruit inventory that was not acquired by the Purchasers.

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 30, 2023
Inventory Disclosure [Abstract]
Schedule of Inventory, Current [Table Text Block]	December 30, 2023 December 31, 2022 $ $ Raw materials and work-in-process 52,419 46,723 Finished goods 37,606 31,014 Inventory reserve (6,810 ) (3,298 ) 83,215 74,439
Schedule of Inventory Reserve [Table Text Block]	December 30, 2023 December 31, 2022 $ $ Balance, beginning of year 3,298 1,604 Additions to reserve during the year 9,255 5,625 Reserves applied and inventories written off during the year (5,743 ) (3,931 ) Balance, end of year 6,810 3,298

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	12 Months Ended
	Dec. 30, 2023
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment [Table Text Block]	December 30, 2023 December 31, 2022 Cost Accumulated Net book Cost Accumulated Net book $ $ $ $ $ $ Land 238 - 238 238 - 238 Buildings 102,211 21,641 80,570 104,835 16,721 88,114 Machinery and equipment 323,653 95,254 228,399 271,877 78,029 193,848 Enterprise software 16,847 8,156 8,691 22,717 14,750 7,967 Office furniture and equipment 3,568 1,715 1,853 3,719 1,767 1,952 Vehicles 405 258 147 492 305 187 446,922 127,024 319,898 403,878 111,572 292,306

Leases (Tables)

Leases (Tables)	12 Months Ended
	Dec. 30, 2023
Leases [Abstract]
Schedule of Lease Costs [Table Text Block]	December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Lease Costs Operating lease cost 15,076 13,099 11,789 Finance lease cost: Depreciation of right-of-use assets 13,441 9,816 5,592 Interest on lease liabilities 9,310 5,136 2,727 Total finance lease cost 22,751 14,952 8,319
Schedule of Balance Sheet Classification, Cash Flow Information, Other Information [Table Text Block]	December 30, 2023 December 31, 2022 $ $ Balance Sheet Classification Operating leases: Operating lease right-of-use assets 105,919 78,761 Current portion of operating lease liabilities 15,808 12,499 Operating lease liabilities 100,102 74,329 Total operating lease liabilities 115,910 86,828 Finance leases: Property, plant and equipment, gross 81,423 153,976 Accumulated depreciation (18,319 ) (18,168 ) Property, plant and equipment, net 63,104 135,808 Current portion of long-term debt 15,346 33,283 Long-term debt 37,284 90,796 Total finance lease liabilities 52,630 124,079 December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Cash Flow Information Cash paid (received) for amounts included in measurement of lease liabilities: Operating cash flows from operating leases 13,852 12,320 11,098 Operating cash flows from finance leases 9,310 5,136 2,727 Financing cash flows from finance leases Cash paid under finance leases (1) 89,087 19,903 8,439 Cash received under finance leases (2) (6,568 ) (58,764 ) (13,626 ) Right-of-use assets obtained in exchange for lease liabilities: Operating leases 35,601 49,662 27,909 Finance leases 9,651 31,466 29,906 Right-of-use assets and liabilities reduced through lease terminations or modifications: Operating leases (914 ) (4,060 ) (2,261 ) (1) Represents repayments under finance leases recorded as a reduction of the lease liability and reported in repayment of long-term debt on the consolidated statements of cash flows. For the year ended December 30, 2023, lease repayments include $56.0 million paid by the Company to terminate certain finance lease obligations and purchase the related underlying right-of-use assets in connection with the refinancing of the Company's credit facilities on December 8, 2023 (see note 10). The difference of $4.4 million between the purchase price and the carrying amount of the finance lease obligations is reported in additions to property, plant and equipment on the consolidated statement of cash flows for the year ended December 30, 2023. (2) Represents cash advances received by the Company under finance leases for the construction of right-of-use assets controlled by the Company, which related to the buildouts of the Company's new plant-based beverage facility in Midlothian, Texas, and the Company's executive office and innovation center located in Eden Prairie, Minnesota, as well as cash proceeds under sale and leaseback transactions accounted for as financings. Cash received under finance leases is reported in borrowings of long-term debt on the consolidated statements of cash flows. December 30, 2023 December 31, 2022 January 1, 2022 Other Information Weighted-average remaining lease term (years): Operating leases 12.0 12.9 7.6 Finance leases 3.2 3.5 4.3 Weighted-average discount rate: Operating leases 8.7% 8.8% 5.1% Finance leases 7.9% 8.2% 6.6%
Schedule of Lease Liabilities Maturities [Table Text Block]	Operating leases Finance leases $ $ Maturities of Lease Liabilities 2024 16,364 17,834 2025 16,410 20,199 2026 15,564 16,423 2027 14,559 4,458 2028 14,374 1,398 Thereafter 167,412 - Total lease payments 244,683 60,312 Less: imputed interest (128,773 ) (7,682 ) Total lease liabilities 115,910 52,630

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
	Dec. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]	December 30, 2023 December 31, 2022 Cost Accumulated Net book Cost Accumulated Net book $ $ $ $ $ $ Brand names 25,073 4,517 20,556 25,073 2,845 22,228 Customer relationships 2,251 946 1,305 2,251 833 1,418 27,324 5,463 21,861 27,324 3,678 23,646
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	2024 2025 2026 2027 2028 Thereafter Total $ $ $ $ $ $ $ Amortization expense 1,784 1,784 1,784 1,784 1,784 12,941 21,861

Accounts Payable and Accrued _2

Accounts Payable and Accrued Liabilities (Tables)	12 Months Ended
	Dec. 30, 2023
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	December 30, 2023 December 31, 2022 $ $ Accounts payable 75,761 76,025 Payroll and benefits 11,841 13,639 Accrued interest 1,379 1,685 Accrued severance costs 1,273 - Accrued product recall-related costs (see note 17) 1,250 - Dividends payable on preferred stock (see note 11) 304 609 Other accruals 4,842 3,921 96,650 95,879

Long-Term Debt (Tables)

Long-Term Debt (Tables)	12 Months Ended
	Dec. 30, 2023
Debt Disclosure [Abstract]
Schedule of Line of Credit Facilities [Table Text Block]	December 30, 2023 December 31, 2022 $ $ Term loan facilities 180,000 43,748 Revolving credit facilities 31,751 137,253 Less: Unamortized debt issuance costs (1,152 ) - Total credit facilities 210,599 181,001 Finance lease liabilities (see note 6) 52,630 124,079 Other - 3,404 Total debt 263,229 308,484 Less: current portion 24,346 38,491 Total long-term debt 238,883 269,993
Schedule of Maturities of Long-term Debt [Table Text Block]	$ 2024 26,834 2025 29,199 2026 29,923 2027 17,958 2028 168,149 Total gross maturities 272,063 Less: imputed interest on finance lease liabilities (7,682 ) Less: debt issuance costs (1,152 ) Total debt 263,229
Schedule of Interest Expense and Interest Income [Table Text Block]	December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Interest expense, net of capitalized interest (see note 5) 24,422 11,889 6,462 Amortization of debt issuance costs 1,398 1,601 1,353 Loss on extinguishment of debt 1,584 - - Interest income (495 ) (334 ) (263 ) Interest expense, net 26,909 13,156 7,552

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Non-Vested PSU Activity [Table Text Block]	Weighted- average grant- TSR PSUs date fair value Non-vested, beginning of year 594,873 $ 10.07 Granted 405,212 7.00 Vested - - Forfeited (443,405 ) 8.61 Non-vested, end of year 556,680 $ 9.00
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Stock Option Activity [Table Text Block]	Weighted- average Weighted- remaining average contractual Aggregate Stock options exercise price term (years) intrinsic value Outstanding, beginning of year 3,920,600 $ 5.51 Granted 534,657 6.29 Exercised (310,167 ) 2.79 Forfeited (771,987 ) 6.53 Expired (25,000 ) 7.36 Outstanding, end of year 3,348,103 $ 5.63 6.5 $ 2,318 Exercisable, end of year 2,125,112 $ 5.33 5.2 $ 2,318 Weighted- average grant- Stock options date fair value Non-vested, beginning of year 1,965,839 $ 3.63 Granted 534,657 3.87 Vested (786,033 ) 3.64 Forfeited (491,472 ) 3.79 Non-vested, end of year 1,222,991 $ 3.67
Schedule of Stock Options Granted using the Black-Scholes Option Pricing Model [Table Text Block]	December 30, 2023 December 31, 2022 January 1, 2022 Grant-date stock price $ 6.29 $ 5.91 $ 14.77 Dividend yield (a) 0% 0% 0% Expected volatility (b) 63.5% 61.6% 61.7% Risk-free interest rate (c) 4.1% 3.0% 1.0% Expected life of options (years) (d) 6.0 6.0 6.0 (a) Determined based on expected annual dividend yield at the time of grant. (b) Determined based on historical volatility of the Company's Common Shares over the expected life of the option. (c) Determined based on the yield on U.S. Treasury zero-coupon issues with maturity dates equal to the expected life of the option. (d) Determined based on the mid-point of vesting (one through three years) and expiration (10 years). The Company has used the simplified method to determine the expected life of options due to insufficient historical exercise data to provide a reasonable basis to estimate the expected life.
Schedule of Share-based Compensation Arrangements by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	Weighted- average remaining Weighted- Weighted- Exercise price range Outstanding contractual life average exercise Exercisable average exercise Low High options (years) price options price $ 3.25 $ 3.73 1,016,553 5.2 $ 3.35 1,016,553 $ 3.35 3.74 5.69 278,998 5.1 4.87 242,640 4.78 5.70 6.13 1,402,892 8.0 5.91 505,767 5.91 6.14 9.48 327,235 8.2 6.51 62,005 7.19 9.49 14.77 322,425 3.3 11.40 298,147 11.12 3,348,103 6.5 $ 5.63 2,125,112 $ 5.33
Restricted Stock Units ("RSUs") [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]	Weighted- average grant- RSUs date fair value Non-vested, beginning of year 659,649 $ 7.14 Granted 443,247 5.88 Vested (380,577 ) 6.57 Forfeited (122,595 ) 7.14 Non-vested, end of year 599,724 $ 6.58
Performance Share Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of Stock Options Granted using the Black-Scholes Option Pricing Model [Table Text Block]	December 30, 2023 December 31, 2022 January 1, 2022 Grant-date stock price $ 6.35 $ 5.91 $ 14.77 Dividend yield 0% 0% 0% Expected volatility (a) 55.5% 67.8% 76.9% Risk-free interest rate (b) 4.7% 2.8% 0.3% Expected life (in years) (c) 2.5 2.7 2.7 (a) Determined based on the historical volatility of the Common Shares over the performance period of the PSUs. (b) Determined based on U.S. Treasury yields with a remaining term equal to the performance period of the PSUs. (c) Determined based on the performance period of the PSUs.
Schedule of Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]	Weighted- average grant- EBITDA PSUs date fair value Non-vested, beginning of year 2,355,431 $ 4.80 Granted 1,137,057 6.96 Vested (2,299,700 ) 4.78 Cancelled or forfeited (191,892 ) 6.55 Non-vested, end of year 1,000,896 $ 6.95

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 30, 2023
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Earnings (loss) from continuing operations before income taxes (18,641 ) 4,777 689 Canadian statutory rate 26.5% 26.5% 26.5% Income tax expense (benefit) at statutory rate (4,940 ) 1,266 183 Stock-based compensation (778 ) 1,054 (4,714 ) Change in valuation allowance 5,911 (471 ) 975 Disallowed executive compensation 2,372 367 135 Foreign tax rate differential 107 (156 ) (73 ) Change in enacted tax rates 90 (9 ) 17 Other 507 (1,155 ) (1,377 ) Income tax expense (benefit) 3,269 896 (4,854 ) December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Canada (9,202 ) (11,455 ) (10,522 ) U.S. (9,439 ) 16,232 11,211 Earnings (loss) from continuing operations before income taxes (18,641 ) 4,777 689 December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Current income tax expense (benefit): Canada (32 ) 84 (9 ) U.S. (677 ) 1,108 (283 ) (709 ) 1,192 (292 ) Deferred income tax expense (benefit): Canada - - 299 U.S. 3,978 (296 ) (4,861 ) 3,978 (296 ) (4,562 ) Income tax expense (benefit) 3,269 896 (4,854 )
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	December 30, 2023 December 31, 2022 $ $ Loss and credit carryovers 43,871 20,201 Lease liabilities 29,395 23,609 Interest expense limitation (163j) 15,906 9,464 Inventory basis differences 3,723 1,805 Stock-based compensation 1,255 2,160 Right-of-use lease assets (28,285 ) (23,071 ) Property, plant and equipment and intangible assets (18,537 ) (28,088 ) Other 2,623 2,458 49,951 8,538 Less: valuation allowance 50,456 4,826 Deferred income tax asset (liability) (505 ) 3,712
Schedule of Deferred Tax Assets and Liabilities by Geographic Segment [Table Text Block]	December 30, 2023 December 31, 2022 $ $ Canada (325 ) (325 ) U.S. - 3,978 Other (180 ) 59 Deferred income tax asset (liability) (505 ) 3,712
Schedule of Deferred Income Tax Valuation Allowance [Table Text Block]	December 30, 2023 December 31, 2022 $ $ Balance, beginning of year 4,826 5,267 Increase (decrease) in valuation allowance 45,630 (441 ) Balance, end of year 50,456 4,826
Schedule of Net Operating Losses, Tax Credits and Capital Losses Recorded Deferred Tax Assets [Table Text Block]	Gross attribute amount Net attribute amount Expiration years Tax Attributes Net operating losses - Canada $ 2,123 $ 563 2040-2041 Net operating losses - U.S. Federal 145,989 30,658 2037 and indefinite Net operating losses - U.S. State 103,009 5,613 2027-2043 and indefinite Net operating losses - Other 167 50 2028 Federal credits - Canada - 255 N/A Federal credits - U.S. - 2,833 2031-2043 State credits - U.S. - 211 2024-2026 Federal capital loss - Canada 27,838 3,688 N/A Total $ 43,871

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	12 Months Ended
	Dec. 30, 2023
Earnings (Loss) Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	December 30, 2023 December 31, 2022 January 1, 2022 Numerator Earnings (loss) from continuing operations $ (21,910 ) $ 3,881 $ 5,543 Less: dividends and accretion on preferred stock (1,981 ) (3,109 ) (4,197 ) Earnings (loss) from continuing operations attributable to common shareholders (23,891 ) 772 1,346 Loss from discontinued operations (153,108 ) (8,722 ) (6,715 ) Loss attributable to common shareholders $ (176,999 ) $ (7,950 ) $ (5,369 ) Denominator Basic weighted-average number of shares outstanding 114,226 107,659 104,098 Dilutive effect of the following: Stock options and restricted stock units (1) - 2,588 2,889 Series B-1 Preferred Stock (2) - - - Diluted weighted-average number of shares outstanding 114,226 110,247 106,987 Basic Earnings (Loss) Per Share Earnings (loss) from continuing operations $ (0.21 ) $ 0.01 $ 0.01 Loss from discontinued operations (1.34 ) (0.08 ) (0.06 ) Loss attributable to common shareholders $ (1.55 ) $ (0.07 ) $ (0.05 ) Diluted Earnings (Loss) Per Share Earnings (loss) from continuing operations $ (0.21 ) $ 0.01 $ 0.01 Loss from discontinued operations (1.34 ) (0.08 ) (0.06 ) Loss attributable to common shareholders $ (1.55 ) $ (0.07 ) $ (0.05 )

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	12 Months Ended
	Dec. 30, 2023
Supplemental Cash Flow Elements [Abstract]
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]	December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Changes in Operating Assets and Liabilities, Net of Divestitures Accounts receivable (4,034 ) (4,948 ) (5,893 ) Inventories (8,776 ) (10,300 ) (17,780 ) Accounts payable and accrued liabilities (4,805 ) (4,246 ) 23,499 Other operating assets and liabilities (7,384 ) 4,352 3,382 (24,999 ) (15,142 ) 3,208 Non-Cash Investing and Financing Activities Change in additions to property, plant and equipment included in accounts payable and accrued liabilities (436 ) (4,234 ) 3,638 Change in accrued dividends on preferred stock (305 ) - (1,769 ) Estimated net working capital adjustment related to the divestiture of Frozen Fruit (see note 2) (457 ) - - Change in short-term note receivable from divestiture of Frozen Fruit (see note 2) (6,300 ) - - Seller Promissory Notes issued on the divestiture of Frozen Fruit (see note 2) (20,000 ) - - Paid in kind interest on Seller Promissory Notes (300 ) - - Change in proceeds receivable from Sunflower divestiture (1) 385 (385 ) - Change in accrued transaction costs related to the divestiture of Tradin Organic (2) - - (13,380 ) Change in accrued debt issuance costs - - (1,690 ) Cash Paid Interest 24,032 11,093 5,520 Income taxes 569 847 3,632

Disaggregation of Revenue, Ge_2

Disaggregation of Revenue, Geographic Information, and Major Customers (Tables)	12 Months Ended
	Dec. 30, 2023
Segment Reporting [Abstract]
Schedule of Disaggregation of Revenue [Table Text Block]	December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Product Category Beverages and broths (1) 502,793 454,446 372,398 Fruit Snacks 98,186 82,869 62,742 Ingredients (1), (2) 17,032 45,366 61,315 Smoothie bowls (3) 12,286 8,714 - Total revenues 630,297 591,395 496,455 (1) For the year ended December 30, 2023, the Company reclassified certain product sales that were previously recorded in Beverages and Broths to Ingredients to better reflect the nature of the product offerings. The comparative figures for the years ended December 31, 2022 and January 1, 2022 have been conformed to the current year presentation. (2) For the year ended January 1, 2022, ingredient revenues include $26.1 million from the production and sale of fruit-based ingredients for industrial use prior to the Company's rationalization of the product line in July 2021. (3) As described in note 19, on February 23, 2024, the Company entered into an agreement to sell the assets related to its smoothie bowl product line.
Schedule of Segment Revenue from External Customers by Segment [Table Text Block]	December 30, 2023 December 31, 2022 January 1, 2022 $ $ $ Revenues from External Customers U.S. 615,133 577,515 483,544 Canada 11,740 8,973 9,319 Other 3,424 4,907 3,592 Total revenues from external customers 630,297 591,395 496,455
Schedule of Segment Long-lived Assets by Geographic Areas [Table Text Block]	December 30, 2023 December 31, 2022 $ $ Long-Lived Assets U.S. 317,830 290,266 Canada 2,068 2,040 Total long-lived assets 319,898 292,306
Schedule of Segment Reporting Information, by Segment [Table Text Block]	December 30, 2023 December 31, 2022 January 1, 2022 Customer A 34% 31% 30% Customer B 8% 14% 13%

Quarterly Results of Operatio_2

Quarterly Results of Operations (unaudited) (Tables)	12 Months Ended
	Dec. 30, 2023
Quarterly Financial Information Disclosure [Abstract]
Schedule of Quarterly Financial Information [Table Text Block]	Fiscal 2023 First Second Third Fourth Quarter Quarter Quarter Quarter $ $ $ $ Revenues 154,969 141,163 152,541 181,624 Gross profit 24,079 18,629 20,268 25,641 Loss from continuing operations (2,827 ) (11,651 ) (5,680 ) (1,752 ) Earnings (loss) from discontinued operations 4,204 (7,187 ) (140,143 ) (9,982 ) Net earnings (loss) 1,377 (18,838 ) (145,823 ) (11,734 ) Dividends and accretion of preferred stock (704 ) (422 ) (426 ) (429 ) Earnings (loss) attributable to common shareholders 673 (19,260 ) (146,249 ) (12,163 ) Basic and diluted earnings (loss) per share: Loss from continuing operations (0.03 ) (0.10 ) (0.05 ) (0.02 ) Earnings (loss) from discontinued operations 0.04 (0.06 ) (1.21 ) (0.09 ) Earnings (loss) attributable to common shareholders (1) 0.01 (0.17 ) (1.26 ) (0.11 ) Fiscal 2022 First Second Third Fourth Quarter Quarter Quarter Quarter $ $ $ $ Revenues 139,517 148,065 144,023 159,790 Gross profit 23,769 27,013 25,132 23,816 Earnings (loss) from continuing operations 1,021 928 2,359 (427 ) Earnings (loss) from discontinued operations 3,547 543 (14,293 ) 1,481 Net earnings (loss) 4,568 1,471 (11,934 ) 1,054 Dividends and accretion of preferred stock (755 ) (760 ) (764 ) (830 ) Earnings (loss) attributable to common shareholders 3,813 711 (12,698 ) 224 Basic and diluted earnings (loss) per share: Earnings from continuing operations 0.00 0.00 0.01 (0.01 ) Earnings (loss) from discontinued operations 0.03 0.01 (0.13 ) 0.01 Earnings (loss) attributable to common shareholders (1) 0.04 0.01 (0.12 ) 0.00 (1)

Significant Accounting Polici_4

Significant Accounting Policies (Narrative) (Details)	12 Months Ended
	Dec. 30, 2023
Significant Accounting Policies [Line Items]
Operating cycle	The fiscal year of the Company consists of a 52- or 53-week period ending on the Saturday closest to December 31. Fiscal years 2023, 2022 and 2021 were each 52-week periods ending on December 30, 2023, December 31, 2022 and January 1, 2022, respectively. Fiscal year 2024 will be a 52-week period ending on December 28, 2024, with quarterly periods ending on March 30, 2024, June 29, 2024, and September 28, 2024.
Description of trade receivable balance	As at December 30, 2023, two long-term customers represented approximately 33% and 14%, respectively, of the Company's consolidated accounts receivable balance.
Description of threshold limit of income tax positions	for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the related tax authority.
Customer relationships [Member]
Significant Accounting Policies [Line Items]
Finite-Lived Intangible Asset, Useful Life	20 years
Brand names [Member]
Significant Accounting Policies [Line Items]
Finite-Lived Intangible Asset, Useful Life	15 years

Significant Accounting Polici_5

Significant Accounting Policies (Schedule of useful life for property plant and equipment) (Details)	Dec. 30, 2023
Buildings [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	20 years
Buildings [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	40 years
Machinery and equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	5 years
Machinery and equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	20 years
Enterprise software [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	3 years
Enterprise software [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	5 years
Office furniture and equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	3 years
Office furniture and equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	7 years
Vehicles [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	3 years
Vehicles [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	7 years

Discontinued Operations (Narrat

Discontinued Operations (Narrative) (Details) - USD ($) $ in Thousands		12 Months Ended
	Oct. 12, 2023	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Repayment of portion of outstanding borrowings		$ 95,303	$ 20,085	$ 8,502
Divestiture of Frozen Fruit [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on divestiture		(119,821)	(31,468)	0
Impairment charges for inventory		12,900
Impairment charge related to the equipment and operating lease right-of-use assets		10,000
Gain on sale of frozen fruit processing facility			3,800
Income tax benefit		167	16,154	$ 1,574
Divestiture of Frozen Fruit [Member] | Asset Purchase Agreement [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash consideration	$ 95,300
Short-term note receivable	10,500	6,300
Receivable amount in five consecutive monthly installments	2,100
Accounts payable and accrued liabilities assumed	15,700
Repayments of certain bank loans and other liabilities	20,500
Repayment of portion of outstanding borrowings	$ 74,800
Interest rate per annum	The Seller Promissory Notes bear interest at a rate per annum equal to the Secured Overnight Financing Rate ("SOFR"), determined quarterly in advance, plus a margin of 4.00% for the first year and 7.00% for the second and third years. Interest is payable quarterly in-kind. The Seller Promissory Notes mature on October 12, 2026, and outstanding principal and accrued and unpaid interest is payable on the maturity date.
Unrealized loss (gain) on derivative instrument	$ 400
Maximum deduction from principal amount of Seller Promissory Notes		5,000
Net Receivable from Purchasers		$ 500
Sunrise Growers [Member] | Asset Purchase Agreement [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Principal amount of seller promissory notes	5,000
Sunopta Mexico [Member] | Asset Purchase Agreement [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Principal amount of seller promissory notes	$ 15,000
Sale of Sunflower Business [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on divestiture			(23,200)
Tradin Organic [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on divestiture			(8,200)
Income tax benefit			$ 12,900

Discontinued Operations (Schedu

Discontinued Operations (Schedule of income statement disclosures) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 30, 2023	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss from discontinued operations	$ (9,982)	$ (140,143)	$ (7,187)	$ 4,204	$ 1,481	$ (14,293)	$ 543	$ 3,547	$ (153,108)	$ (8,722)	$ (6,715)
Divestiture of Frozen Fruit [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues									200,029	343,267	316,169
Cost of goods sold									211,467	320,143	299,593
Selling, general and administrative expenses									8,683	10,843	11,821
Intangible asset amortization									6,000	8,498	8,664
Other expense (income), net									10,112	(2,746)	2,145
Foreign exchange loss (gain)									(3,333)	(1,641)	1,018
Interest expense, net									554	1,578	1,217
Earnings (loss) before loss on divestiture									(33,454)	6,592	(8,289)
Pre-tax loss on divestiture									(119,821)	(31,468)	0
Loss from discontinued operations before income taxes									(153,275)	(24,876)	(8,289)
Income tax benefit									(167)	(16,154)	(1,574)
Loss from discontinued operations									$ (153,108)	$ (8,722)	$ (6,715)

Discontinued Operations (Sche_2

Discontinued Operations (Schedule of assets and liabilities held for sale test) (Details) - Divestiture of Frozen Fruit [Member] - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022
Assets
Accounts receivable	$ 0	$ 15,358
Inventories	5,910	132,608
Other current assets	0	153
Property, plant and equipment, net	0	30,085
Operating lease right-of-use assets	0	3,803
Intangible assets, net	0	112,000
Total assets held for sale	5,910	294,007
Liabilities
Accounts payable and accrued liabilities	0	12,632
Operating lease liabilities	0	3,803
Total liabilities held for sale	$ 0	$ 16,435

Inventories (Schedule of invent

Inventories (Schedule of inventory, current) (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Inventory Disclosure [Abstract]
Raw materials and work-in-process	$ 52,419	$ 46,723
Finished goods	37,606	31,014
Inventory reserves	(6,810)	(3,298)	$ (1,604)
Total Inventory, Net	$ 83,215	$ 74,439

Inventories (Schedule of inve_2

Inventories (Schedule of inventory reserve) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022
Inventories [Roll Forward]
Balance, beginning of year	$ 3,298	$ 1,604
Additions to reserve during the year	9,255	5,625
Reserves applied and inventories written off during the year	(5,743)	(3,931)
Balance, end of year	$ 6,810	$ 3,298

Property, Plant and Equipment_2

Property, Plant and Equipment (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Property, Plant and Equipment [Line Items]
Interest expense capitalized	$ 0.3	$ 1.2
Construction in process assets	33.3	128.4
Spare parts inventory	11.1	8.8
Depreciation	$ 29.3	$ 21.3	$ 17.3

Property, Plant and Equipment_3

Property, Plant and Equipment (Schedule of property, plant and equipment) (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Cost	$ 446,922	$ 403,878
Accumulated depreciation	127,024	111,572
Net book value	319,898	292,306
Land [Member]
Property, Plant and Equipment [Line Items]
Cost	238	238
Accumulated depreciation	0	0
Net book value	238	238
Building [Member]
Property, Plant and Equipment [Line Items]
Cost	102,211	104,835
Accumulated depreciation	21,641	16,721
Net book value	80,570	88,114
Machinery and equipment [Member]
Property, Plant and Equipment [Line Items]
Cost	323,653	271,877
Accumulated depreciation	95,254	78,029
Net book value	228,399	193,848
Enterprise software [Member]
Property, Plant and Equipment [Line Items]
Cost	16,847	22,717
Accumulated depreciation	8,156	14,750
Net book value	8,691	7,967
Office furniture and equipment [Member]
Property, Plant and Equipment [Line Items]
Cost	3,568	3,719
Accumulated depreciation	1,715	1,767
Net book value	1,853	1,952
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Cost	405	492
Accumulated depreciation	258	305
Net book value	$ 147	$ 187

Leases (Narrative) (Details)

Leases (Narrative) (Details) $ in Millions	12 Months Ended
	Dec. 30, 2023 USD ($)
Operating Leased Assets [Line Items]
Lease repayments involve termination of finance leases and asset acquisition	$ 56
Substantial difference in purchase price and the carrying amount of the finance lease obligations	$ 4.4
Lessee, finance lease, lease not yet commenced, description	As at December 30, 2023, the Company had entered into a finance lease agreement to provide for approximately $25 million of financing related to an expansion of the Company's ingredient extraction operations at its Modesto, California, facility, which is expected to become operational during the first half of 2024. As this finance lease had not commenced as at December 30, 2023, no amount of underlying right-of-use assets, or lease liabilities, were recognized on the consolidated balance sheet as of that date.
Minimum [Member]
Operating Leased Assets [Line Items]
Lessee, operating lease, term of contract	1 year
Maximum [Member]
Operating Leased Assets [Line Items]
Lessee, operating lease, term of contract	15 years
Real estate operating leases [Member] | Maximum [Member]
Operating Leased Assets [Line Items]
Lessee, operating lease, renewal term	15 years

Lease (Schedule of cost) (Detai

Lease (Schedule of cost) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Lease Costs
Operating lease cost	$ 15,076	$ 13,099	$ 11,789
Finance lease cost, Depreciation of right-of-use assets	13,441	9,816	5,592
Finance lease cost, Interest on lease liabilities	9,310	5,136	2,727
Total finance lease cost	$ 22,751	$ 14,952	$ 8,319

Leases (Schedule of balance she

Leases (Schedule of balance sheet classification) (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022
Operating leases
Operating lease right-of-use assets	$ 105,919	$ 78,761
Current portion of operating lease liabilities	15,808	12,499
Operating lease liabilities	100,102	74,329
Total operating lease liabilities	115,910	86,828
Finance leases
Property, plant and equipment, gross	446,922	403,878
Accumulated depreciation	(127,024)	(111,572)
Property, plant and equipment, net	319,898	292,306
Current portion of long-term debt	15,346	33,283
Long-term debt	37,284	90,796
Finance lease liabilities	52,630	124,079
Finance Leases [Member]
Finance leases
Property, plant and equipment, gross	81,423	153,976
Accumulated depreciation	(18,319)	(18,168)
Property, plant and equipment, net	$ 63,104	$ 135,808

Leases (Schedule of cash flow i

Leases (Schedule of cash flow information) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Cash paid (received) for amounts included in measurement of lease liabilities:
Operating cash flows from operating leases	$ 13,852	$ 12,320	$ 11,098
Operating cash flows from finance leases	9,310	5,136	2,727
Financing cash flows from finance leases
Cash paid under finance leases	89,087	19,903	8,439
Cash received under finance leases	(6,568)	(58,764)	(13,626)
Right-of-use assets obtained in exchange for lease liabilities:
Operating leases	35,601	49,662	27,909
Finance Leases	9,651	31,466	29,906
Operating Leases [Member]
Right-of-use assets and liabilities reduced through lease terminations or modifications:
Operating leases	$ (914)	$ (4,060)	$ (2,261)

Leases (Schedule of other infor

Leases (Schedule of other information) (Details)	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Leases [Abstract]
Weighted-average remaining lease term (years), Operating leases	12 years	12 years 10 months 24 days	7 years 7 months 6 days
Weighted-average remaining lease term (years), Finance leases	3 years 2 months 12 days	3 years 6 months	4 years 3 months 18 days
Weighted-average discount rate, Operating leases	8.70%	8.80%	5.10%
Weighted-average discount rate, Finance leases	7.90%	8.20%	6.60%

Leases (Schedule of lessee, ope

Leases (Schedule of lessee, operating lease liability, maturity) (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022
Operating leases
2024	$ 16,364
2025	16,410
2026	15,564
2027	14,559
2028	14,374
Thereafter	167,412
Total lease payments	244,683
Less: imputed interest	(128,773)
Total lease liabilities	115,910	$ 86,828
Finance leases
2024	17,834
2025	20,199
2026	16,423
2027	4,458
2028	1,398
Thereafter	0
Total lease payments	60,312
Less: imputed interest on finance lease liabilities	(7,682)
Total lease liabilities	$ 52,630	$ 124,079

Intangible assets (Schedule of

Intangible assets (Schedule of major components) (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Cost	$ 27,324	$ 27,324
Accumulated amortization	5,463	3,678
Net book value	21,861	23,646
Brand names [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	25,073	25,073
Accumulated amortization	4,517	2,845
Net book value	20,556	22,228
Customer relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	2,251	2,251
Accumulated amortization	946	833
Net book value	$ 1,305	$ 1,418

Intangible assets (Schedule o_2

Intangible assets (Schedule of future amortization) (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
2024	$ 1,784
2025	1,784
2026	1,784
2027	1,784
2028	1,784
Thereafter	12,941
Total	$ 21,861	$ 23,646

Accounts Payable and Accrued _3

Accounts Payable and Accrued Liabilities (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accounts payable	$ 75,761	$ 76,025
Payroll and benefits	11,841	13,639
Accrued interest	1,379	1,685
Accrued severance costs	1,273	0
Accrued product recall-related costs	1,250	0
Dividends payable on preferred stock	304	609
Other accruals	4,842	3,921
Accounts payable and accrued liabilities	$ 96,650	$ 95,879

Notes Payable (Narrative) (Deta

Notes Payable (Narrative) (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Notes payable	$ 17,596	$ 0

Long-Term Debt (Narrative) (Det

Long-Term Debt (Narrative) (Details) - USD ($) $ in Thousands		12 Months Ended
	Dec. 08, 2023	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Debt Instrument [Line Items]
Unamortized debt issuance costs		$ 1,152	$ 0
Line of Credit Facility, Frequency of Payments	The New Credit Facilities mature on December 8, 2028. Borrowings under the New Term Loan Credit Facility are repayable in quarterly principal installments of $2.3 million from the fiscal quarter ending March 31, 2024 to the fiscal quarter ending December 31, 2025, $3.4 million from the fiscal quarter ending March 31, 2026 to the fiscal quarter ending December 31, 2027, and $4.5 million from the fiscal quarter ending March 31, 2028 to the fiscal quarter ending September 30, 2028, with the remaining principal balance of $121.5 million due on the maturity date.
Loss on the retirement of note		1,584	$ 0	$ 0
Letter of Credit [Member]
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 30,000	$ 5,900
New Credit Agreement [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Borrowing Capacity, Description	(i) a $180.0 million term loan credit facility (the "New Term Loan Credit Facility") and (ii) an $85.0 million revolving credit facility (the "New Revolving Credit Facility" and together with the New Term Loan Credit Facility, the "New Credit Facilities").
Line of Credit Facility, Interest Rate Description		Borrowings under the New Credit Facilities bear interest at a margin over various reference rates, including a base rate (as defined in the New Credit Agreement) and SOFR, selected at the option of the Company. The margin for the New Credit Facilities will be set quarterly based on the consolidated total net leverage ratio for the preceding fiscal quarter and will range from 1.00% to 2.25% with respect to base rate loans and from 2.00% to 3.25% for SOFR loans. Prior to the completion of the fiscal quarter ending March 31, 2024, the initial margins for the New Credit Facilities are 1.75% and 2.75% with respect to base rate and SOFR loans, respectively. As at December 30, 2023, the interest rate on outstanding borrowings under the New Credit Facilities was 8.22%. In addition, the Company is required to pay an undrawn fee under the New Revolving Credit Facility quarterly based on the consolidated total net leverage ratio for the preceding fiscal quarter ranging from 0.20% to 0.40% on the undrawn revolving commitments thereunder. The Company is also required to pay customary letter of credit fees, to the extent letters of credit are issued and outstanding under the New Revolving Credit Facility.
Debt issuance costs	$ 1,000
Allocation of Debt Issuance Costs	The Company incurred $2.2 million of debt issuance costs in connection with the New Credit Facilities, of which $1.2 million was allocated to the New Term Loan Credit Facility and recorded as a deduction to long-term debt, and $1.0 million was allocated to the New Revolving Credit Facility and recorded as deferred financing costs in other long-term assets.
New Credit Agreement [Member] | Same-day Notice [Member]
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity	$ 10,000
New Credit Facilities [Member]
Debt Instrument [Line Items]
Line of credit facility, covenant terms		The New Credit Facilities contain a number of covenants that, among other things, restrict, subject to certain exceptions, the Company's ability to: create liens on assets; sell assets and enter into sale and leaseback transactions; pay dividends, prepay contractually subordinated indebtedness and make other restricted payments; incur additional indebtedness and make guarantees; make investments, loans or advances, including acquisitions; engage in certain transactions with affiliates; fundamentally change the character of the Company's business; enter into contractual obligations that restrict the ability of the Company or any Subsidiary Guarantor to grant a lien on its assets in favor of the lenders and other secured creditors under the New Credit Facilities; and engage in mergers or consolidations. In addition, the Company is required to (i) maintain a minimum fixed charge coverage ratio of 1.20 to 1.00 as of the end of each quarterly test period and (ii) maintain a maximum consolidated total net leverage ratio of 4.00 to 1.00 for each quarterly test period prior to the fiscal quarter ending December 31, 2024, 3.75 to 1.00 for each quarterly test period from the fiscal quarter ending December 31, 2024 through the fiscal quarter ending September 30, 2025, and 3.50 to 1.00 for each quarterly test period for the fiscal quarter ending December 31, 2025 and thereafter; provided that, if the Company consummates an acquisition for consideration in excess of $50 million in any quarterly test period, then the maximum consolidated total net leverage ratio may, at the election of the Company (on no more than two occasions), be increased to the lesser of (x) 4.25 to 1.00 and (y) the then applicable maximum consolidated leverage ratio plus 0.50 to 1.00, for the end of the four succeeding quarterly test periods.
Debt issuance costs	2,200
Loss on the retirement of note	(1,600)
Term Loan Facility [Member]
Debt Instrument [Line Items]
Repayments of Lines of Credit	141,900
Repayment of outstanding borrowings	56,000
Loss on the retirement of note	(500)
Third Party Costs [Member]
Debt Instrument [Line Items]
Loss on the retirement of note	$ (1,100)

Long-Term Debt (Schedule of Lin

Long-Term Debt (Schedule of Line of Credit Facilities) (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022
Line of Credit Facility [Line Items]
Total credit facilities	$ 210,599	$ 181,001
Less: Unamortized debt issuance costs	(1,152)	0
Finance lease liabilities	52,630	124,079
Other	0	3,404
Total debt	263,229	308,484
Less: current portion	24,346	38,491
Total long-term debt	238,883	269,993
Revolving credit facilities [Member]
Line of Credit Facility [Line Items]
Total credit facilities	31,751	137,253
Term loan facilities [Member]
Line of Credit Facility [Line Items]
Total credit facilities	$ 180,000	$ 43,748

Long-Term Debt (Schedule of Mat

Long-Term Debt (Schedule of Maturities of Long-term Debt) (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
2024	$ 26,834
2025	29,199
2026	29,923
2027	17,958
2028	168,149
Total gross maturities	272,063
Less: imputed interest on finance lease liabilities	(7,682)
Less: debt issuance costs	(1,152)	$ 0
Total debt	$ 263,229	$ 308,484

Long-Term Debt (Schedule of Int

Long-Term Debt (Schedule of Interest Expense and Interest Income) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Debt Disclosure [Abstract]
Interest expense, net of capitalized interest	$ 24,422	$ 11,889	$ 6,462
Amortization of debt issuance costs	1,398	1,601	1,353
Loss on extinguishment of debt	1,584	0	0
Interest income	(495)	(334)	(263)
Interest expense, net	$ 26,909	$ 13,156	$ 7,552

Series B-1 Preferred Stock (Nar

Series B-1 Preferred Stock (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions		1 Months Ended	3 Months Ended	12 Months Ended
	Mar. 03, 2023	Apr. 24, 2020	Mar. 31, 2023	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022	May 19, 2023	Jul. 02, 2020
Series B-1 Preferred Stock [Member]
Temporary Equity [Line Items]
Preferred Stock, Shares Issued		30,000
Preferred Stock, Value, Issued		$ 30
Unamortized issuance costs				$ 0.6	$ 0.7	$ 0.5
Series B-1 Preferred Stock [Member] | Oaktree and Engaged [Member]
Temporary Equity [Line Items]
Preferred Stock, Shares Issued		15,000
Preferred Stock, Dividend Payment Terms		Preferred dividends accrue daily on the Series B-1 preferred stock at an annualized rate of 8.0% of the liquidation preference prior to September 30, 2029, and 10.0% of the liquidation preference thereafter.
Preferred Stock, Liquidation Preference, Value								$ 30.4
Preferred Stock, Liquidation Preference Per Share								$ 1,015
Dividends paid			$ 0.6
Series B-1 Preferred Stock [Member] | Engaged [Member]
Temporary Equity [Line Items]
Number of shares issued for conversion preferred stock	6,089,331
Preferred stock, conversion price	$ 2.5
Shares exchanged as a percentage of shares issued and outstanding	5.30%
Preferred stock value derecognized	$ 14.1
Unamortized issuance costs	1.1
Preferred stock issuance costs	$ 0.2
Redemption price per share	$ 0.00001
Dividends paid			$ 0.2
Series B-1 Preferred Stock [Member] | Oaktree [Member]
Temporary Equity [Line Items]
Preferred Stock, Shares Issued				15,000
Preferred Stock, Dividend Payment Terms				In the first quarter of 2023, the Company paid cash dividends on the Series B-1 Preferred Stock of $0.6 million in the aggregate to Oaktree and Engaged related to the fourth quarter of 2022, together with a cash dividend $0.2 million paid to Engaged for the period from January 1, 2023 to March 3, 2023. In each of the second through fourth quarters of 2023, the Company paid a quarterly cash dividend of $0.3 million to Oaktree on the Series B-1 Preferred Stock, and, as at December 30, 2023, the Company accrued unpaid dividends to Oaktree of $0.3 million for the fourth quarter of 2023, which are recorded in accounts payable and accrued liabilities on the consolidated balance sheet.
Preferred Stock, Convertible, Terms				At any time, Oaktree may exchange the Series B-1 Preferred Stock, in whole or in part, into the number of Common Shares equal to, per share of Series B-1 Preferred Stock, the quotient of the liquidation preference divided by the exchange price of $2.50, while, at any time, SunOpta Foods may cause Oaktree to exchange all of their shares of Series B-1 Preferred Stock if the volume-weighted average price of the Common Shares during the then preceding 20 trading day period is greater than 200% of the exchange price then in effect.
Preferred Stock, Redemption Terms				In addition, at any time on or after April 24, 2025, SunOpta Foods may redeem all of the Series B-1 Preferred Stock for an amount per share equal to the value of the liquidation preference at such time, plus accrued and unpaid dividends.
Dividends paid				$ 0.3
Accrued unpaid dividends				$ 0.3
Special Shares, Series 2 [Member] | Oaktree [Member]
Temporary Equity [Line Items]
Preferred Stock, Shares Issued							2,932,453
Limit of voting rights							19.99%

Stock-Based Compensation (Narra

Stock-Based Compensation (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands		12 Months Ended
	Jan. 02, 2024	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Gross stock-based compensation expense		$ 11,800	$ 13,800	$ 9,100
Intrinsic value of stock options exercised		700
Employee share purchase plan		$ 583	$ 575	$ 583
CEO [Member] | Subsequent Event [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted	288,808
Exercise price of stock option to purchase one common share	$ 5.54
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted		534,657
Exercise price of stock option to purchase one common share		$ 6.29
Weighted-average grant-date fair value of options		$ 3.87	$ 3.49	$ 8.1
Compensation costs related to awards not yet recognized		$ 2,000
Vesting period		1 year 4 months 24 days
Expected life of options (years)		6 years	6 years	6 years
Employee share purchase plan		$ 600	$ 600	$ 600
Employee stock purchase plan (in shares)		120,666	87,850	66,834
Common Shares remained available to be granted		425,566
Restricted Stock Units ("RSUs") [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted		443,247
Weighted-average grant-date fair value of options		$ 5.88	$ 6.4	$ 13.54
Compensation costs related to awards not yet recognized		$ 2,400
Vesting period		1 year 9 months 18 days
Intrinsic value		$ 2,700
Percentage of vesting awards		100%
Restricted Stock Units ("RSUs") [Member] | CEO [Member] | Subsequent Event [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted	144,404
Performance Share Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted		1,137,057
Weighted-average grant-date fair value of options		$ 6.96	5.45	13.9
Compensation costs related to awards not yet recognized		$ 2,300
Vesting period		3 months 18 days
Intrinsic value		$ 18,000
Performance Share Units [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of vesting awards		0%
Performance Share Units [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of vesting awards		200%
Performance Share Units [Member] | Subsequent Event [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of vesting awards	0%
Performance Share Units [Member] | Subsequent Event [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of vesting awards	200%
Performance Share Units [Member] | CEO [Member] | Subsequent Event [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted	230,804
Total Shareholder Return Performance Share Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted		405,212
Weighted-average grant-date fair value of options		$ 7	$ 8.48	$ 23.4
Compensation costs related to awards not yet recognized		$ 2,500
Vesting period		1 year 9 months 18 days
2013 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of securities remained available for issuance under the Plan		3,619,054

Stock-Based Compensation (Sched

Stock-Based Compensation (Schedule of stock option activity) (Details) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 30, 2023 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options Outstanding, Exercisable, end of year | shares	2,125,112
Stock options Exercisable, Weighted-average exercise price end of year | $ / shares	$ 5.33
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Outstanding, beginning of year | shares	3,920,600
Stock options, Granted | shares	534,657
Stock options, Exercised | shares	(310,167)
Stock options, Forfeited | shares	(771,987)
Stock options, Expired | shares	(25,000)
Stock options Outstanding, Outstanding, end of year | shares	3,348,103
Stock options Outstanding, Exercisable, end of year | shares	2,125,112
Stock options Outstanding, Weighted- average exercise price beginning of year | $ / shares	$ 5.51
Stock options, Granted, Weighted- average exercise price | $ / shares	6.29
Stock options, Exercised, Weighted- average exercise price | $ / shares	2.79
Stock options, Forfeited, Weighted- average exercise price | $ / shares	6.53
Stock options, Expired, Weighted- average exercise price | $ / shares	7.36
Stock options Outstanding, Weighted-average exercise price end of year | $ / shares	5.63
Stock options Exercisable, Weighted-average exercise price end of year | $ / shares	$ 5.33
Stock options, Outstanding, Weighted- average remaining contractual term (years)	6 years 6 months
Stock options, Exercisable, Weighted- average remaining contractual term (years)	5 years 2 months 12 days
Stock options, Outstanding, Aggregate intrinsic value | $	$ 2,318
Stock options, Exercisable, Aggregate intrinsic value | $	$ 2,318

Stock-Based Compensation (Sch_2

Stock-Based Compensation (Schedule of non-vested stock option activity) (Details) - Stock Options [Member] - $ / shares	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year	1,965,839
Granted	534,657
Vested	(786,033)
Forfeited	(491,472)
Non-vested, end of year	1,222,991	1,965,839
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Non-vested, beginning of year	$ 3.63
Granted	3.87	$ 3.49	$ 8.1
Vested	3.64
Forfeited	3.79
Non-vested, end of year	$ 3.67	$ 3.63

Stock-Based Compensation (Sch_3

Stock-Based Compensation (Schedule of weighted-average assumptions to determine fair value of stock options granted) (Details) - Stock Options [Member] - $ / shares	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant-date stock price	$ 6.29	$ 5.91	$ 14.77
Dividend yield	0%	0%	0%
Expected volatility	63.50%	61.60%	61.70%
Risk-free interest rate	4.10%	3%	1%
Expected life of options (years)	6 years	6 years	6 years

Stock-Based Compensation (Sch_4

Stock-Based Compensation (Schedule of stock options outstanding and exercisable) (Details)	12 Months Ended
	Dec. 30, 2023 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding options | shares	3,348,103
Weighted- average remaining contractual life (years)	6 years 6 months
Weighted-average exercise price	$ 5.63
Exercisable options | shares	2,125,112
Weighted- average exercise price	$ 5.33
Exercise Price Range 1 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range Low	3.25
Exercise price range High	$ 3.73
Outstanding options | shares	1,016,553
Weighted- average remaining contractual life (years)	5 years 2 months 12 days
Weighted-average exercise price	$ 3.35
Exercisable options | shares	1,016,553
Weighted- average exercise price	$ 3.35
Exercise Price Range 2 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range Low	3.74
Exercise price range High	$ 5.69
Outstanding options | shares	278,998
Weighted- average remaining contractual life (years)	5 years 1 month 6 days
Weighted-average exercise price	$ 4.87
Exercisable options | shares	242,640
Weighted- average exercise price	$ 4.78
Exercise Price Range 3 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range Low	5.7
Exercise price range High	$ 6.13
Outstanding options | shares	1,402,892
Weighted- average remaining contractual life (years)	8 years
Weighted-average exercise price	$ 5.91
Exercisable options | shares	505,767
Weighted- average exercise price	$ 5.91
Exercise Price Range 4 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range Low	6.14
Exercise price range High	$ 9.48
Outstanding options | shares	327,235
Weighted- average remaining contractual life (years)	8 years 2 months 12 days
Weighted-average exercise price	$ 6.51
Exercisable options | shares	62,005
Weighted- average exercise price	$ 7.19
Exercise Price Range 5 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range Low	9.49
Exercise price range High	$ 14.77
Outstanding options | shares	322,425
Weighted- average remaining contractual life (years)	3 years 3 months 18 days
Weighted-average exercise price	$ 11.4
Exercisable options | shares	298,147
Weighted- average exercise price	$ 11.12

Stock-Based Compensation (Sch_5

Stock-Based Compensation (Schedule of non-vested RSU activity) (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year	659,649
Granted	443,247
Vested	(380,577)
Forfeited	(122,595)
Non-vested, end of year	599,724	659,649
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Non-vested, beginning of year	$ 7.14
Granted	5.88	$ 6.4	$ 13.54
Vested	6.57
Forfeited	7.14
Non-vested, end of year	$ 6.58	$ 7.14

Stock-Based Compensation (Sch_6

Stock-Based Compensation (Schedule of non-vested PSU activity) (Details) - EBITDA PSU [Member] - $ / shares	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year	2,355,431
Granted	1,137,057
Vested	(2,299,700)
Forfeited	(191,892)
Non-vested, end of year	1,000,896	2,355,431
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Non-vested, beginning of year	$ 4.8
Granted	6.96	$ 5.45	$ 13.9
Vested	4.78
Forfeited	6.55
Non-vested, end of year	$ 6.95	$ 4.8

Stock-Based Compensation (Sch_7

Stock-Based Compensation (Schedule of TSR PSUs using a Monte Carlo valuation model (Details) - Monte Carlo valuation model [Member] - $ / shares	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant-date stock price	$ 6.35	$ 5.91	$ 14.77
Dividend yield	0%	0%	0%
Expected volatility	55.50%	67.80%	76.90%
Risk-free interest rate	4.70%	2.80%	0.30%
Expected life (in years)	2 years 6 months	2 years 8 months 12 days	2 years 8 months 12 days

Stock-Based Compensation (Sch_8

Stock-Based Compensation (Schedule of non-vested TSR PSU activity (Details) - Total Shareholder Return Performance Share Units [Member] - $ / shares	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year	594,873
Granted	405,212
Vested	0
Forfeited	(443,405)
Non-vested, end of year	556,680	594,873
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Non-vested, beginning of year	$ 10.07
Granted	7	$ 8.48	$ 23.4
Vested	0
Forfeited	8.61
Non-vested, end of year	$ 9	$ 10.07

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Income Tax Disclosure [Abstract]
Deferred tax assets, valuation allowance	$ 50,456	$ 4,826	$ 5,267

Income Taxes (Schedule of compo

Income Taxes (Schedule of components of income tax expense) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Income Tax Disclosure [Abstract]
Earnings (loss) from continuing operations before income taxes	$ (18,641)	$ 4,777	$ 689
Canadian statutory rate	26.50%	26.50%	26.50%
Income tax expense (benefit) at statutory rate	$ (4,940)	$ 1,266	$ 183
Stock-based compensation	(778)	1,054	(4,714)
Change in valuation allowance	5,911	(471)	975
Disallowed executive compensation	2,372	367	135
Foreign tax rate differential	107	(156)	(73)
Change in enacted tax rates	90	(9)	17
Other	507	(1,155)	(1,377)
Income tax expense (benefit)	$ 3,269	$ 896	$ (4,854)

Income Taxes (Schedule of com_2

Income Taxes (Schedule of components of earnings (loss) before income taxes) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Income Tax Disclosure [Line Items]
Earnings (loss) from continuing operations before income taxes	$ (18,641)	$ 4,777	$ 689
Canada [Member]
Income Tax Disclosure [Line Items]
Earnings (loss) from continuing operations before income taxes	(9,202)	(11,455)	(10,522)
U.S. [Member]
Income Tax Disclosure [Line Items]
Earnings (loss) from continuing operations before income taxes	$ (9,439)	$ 16,232	$ 11,211

Income Taxes (Schedule of com_3

Income Taxes (Schedule of components of income tax expense (benefit)) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Income Tax Disclosure [Line Items]
Current income tax expense (benefit)	$ (709)	$ 1,192	$ (292)
Deferred income tax expense (benefit)	3,978	(296)	(4,562)
Income tax expense (benefit)	3,269	896	(4,854)
Canada [Member]
Income Tax Disclosure [Line Items]
Current income tax expense (benefit)	(32)	84	(9)
Deferred income tax expense (benefit)	0	0	299
U.S. [Member]
Income Tax Disclosure [Line Items]
Current income tax expense (benefit)	(677)	1,108	(283)
Deferred income tax expense (benefit)	$ 3,978	$ (296)	$ (4,861)

Income Taxes (Schedule of defer

Income Taxes (Schedule of deferred tax assets and liabilities) (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Income Tax Disclosure [Abstract]
Loss and credit carryovers	$ 43,871	$ 20,201
Lease liabilities	29,395	23,609
Interest expense limitation	15,906	9,464
Inventory basis differences	3,723	1,805
Stock-based compensation	1,255	2,160
Right-of-use lease assets	(28,285)	(23,071)
Property, plant and equipment and intangible assets	(18,537)	(28,088)
Other	2,623	2,458
Gross deferred income tax liability	49,951	8,538
Less: valuation allowance	50,456	4,826	$ 5,267
Deferred income tax (liability)	(505)
Deferred income tax asset	$ 0	$ 3,712

Income Taxes (Schedule of def_2

Income Taxes (Schedule of deferred tax assets and liabilities by geographic segment) (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022
Income Tax Disclosure [Line Items]
Deferred income tax (liability)	$ (505)
Deferred income tax asset	0	$ 3,712
Canada [Member]
Income Tax Disclosure [Line Items]
Deferred income tax (liability)	(325)	(325)
U.S. [Member]
Income Tax Disclosure [Line Items]
Deferred income tax asset	0	3,978
Other [Member]
Income Tax Disclosure [Line Items]
Deferred income tax (liability)	$ (180)
Deferred income tax asset		$ 59

Income Taxes (Schedule of def_3

Income Taxes (Schedule of deferred income tax valuation allowance) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Balance, beginning of year	$ 4,826	$ 5,267
Increase (decrease) in valuation allowance	45,630	(441)
Balance, end of year	$ 50,456	$ 4,826

Income Taxes (Schedule of net o

Income Taxes (Schedule of net operating losses, tax credits and capital losses recorded deferred tax assets) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022
Operating Loss Carryforwards [Line Items]
Total	$ 43,871	$ 20,201
Gross Tax Attributes [Member]
Operating Loss Carryforwards [Line Items]
Net operating losses - Canada	2,123
Net operating losses - U.S. Federal	145,989
Net operating losses - U.S. State	103,009
Net operating losses - Other	167
Federal credits - Canada	0
Federal credits - U.S.	0
State credits - U.S.	0
Federal capital loss - Canada	27,838
Net Tax Attributes [Member]
Operating Loss Carryforwards [Line Items]
Net operating losses - Canada	563
Net operating losses - U.S. Federal	30,658
Net operating losses - U.S. State	5,613
Net operating losses - Other	50
Federal credits - Canada	255
Federal credits - U.S.	2,833
State credits - U.S.	211
Federal capital loss - Canada	3,688
Total	$ 43,871
Expiration Years [Member]
Operating Loss Carryforwards [Line Items]
Net operating losses - Canada	2040-2041
Net operating losses - U.S. Federal	2037 and indefinite
Net operating losses - U.S. State	2027-2043 and indefinite
Net operating losses - Other	2028
Federal credits - Canada	N/A
Federal credits - U.S.	2031-2043
State credits - U.S.	2024-2026
Federal capital loss - Canada	N/A

Earnings (Loss) Per Share (Narr

Earnings (Loss) Per Share (Narrative) (Details) - shares	3 Months Ended		12 Months Ended
	Sep. 30, 2023	Oct. 01, 2022	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount			1,273,093
Stock options and RSUs [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount			2,192,677	2,427,146	347,236
Series B-1 preferred stock [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Common shares issuable on an if-converted basis adjusted to diluted EPS	6,089,333	12,178,667	6,089,333	12,178,667	12,178,677

Earnings (Loss) Per Share (Disc

Earnings (Loss) Per Share (Disclosure of basic and diluted earnings (loss) per share) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 30, 2023	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Numerator for diluted earnings (loss) per share:
Earnings (loss) from continuing operations	$ (1,752)	$ (5,680)	$ (11,651)	$ (2,827)	$ (427)	$ 2,359	$ 928	$ 1,021	$ (21,910)	$ 3,881	$ 5,543
Less: dividends and accretion on preferred stock	$ (429)	$ (426)	$ (422)	$ (704)	$ (830)	$ (764)	$ (760)	$ (755)	(1,981)	(3,109)	(4,197)
Earnings (loss) from continuing operations attributable to common shareholders									(23,891)	772	1,346
Loss from discontinued operations									(153,108)	(8,722)	(6,715)
Loss attributable to common shareholders									$ (176,999)	$ (7,950)	$ (5,369)
Denominator
Basic weighted-average number of shares outstanding									114,226	107,659	104,098
Diluted weighted-average number of shares outstanding									114,226	110,247	106,987
Basic Earnings (Loss) Per Share
Earnings (loss) from continuing operations	$ (0.02)	$ (0.05)	$ (0.1)	$ (0.03)	$ 0.01	$ 0.01	$ 0	$ 0	$ (0.21)	$ 0.01	$ 0.01
Loss from discontinued operations	(0.09)	(1.21)	(0.06)	0.04	(0.01)	(0.13)	0.01	0.03	(1.34)	(0.08)	(0.06)
Loss attributable to common shareholders	$ (0.11)	$ (1.26)	$ (0.17)	$ 0.01	$ 0	$ (0.12)	$ 0.01	$ 0.04	(1.55)	(0.07)	(0.05)
Diluted Earnings (Loss) Per Share
Earnings (loss) from continuing operations									(0.21)	0.01	0.01
Loss from discontinued operations									(1.34)	(0.08)	(0.06)
Loss attributable to common shareholders									$ (1.55)	$ (0.07)	$ (0.05)
Stock options, restricted stock units and performance share units [Member]
Denominator
Diluted weighted-average number of shares outstanding									0	2,588	2,889
Series B-1 Preferred Stock [Member]
Denominator
Diluted weighted-average number of shares outstanding									0	0	0

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Changes in Operating Assets and Liabilities, Net of Divestitures
Accounts receivable	$ (4,034)	$ (4,948)	$ (5,893)
Inventories	(8,776)	(10,300)	17,780
Accounts payable and accrued liabilities	(4,805)	(4,246)	23,499
Other operating assets and liabilities	(7,384)	4,352	3,382
Changes in Non-Cash Working Capital, Net of Businesses Acquired or Sold, Total	(24,999)	(15,142)	3,208
Non-Cash Investing and Financing Activities
Change in additions to property, plant and equipment included in accounts payable and accrued liabilities	(436)	(4,234)	3,638
Change in accrued dividends on preferred stock	(305)	0	(1,769)
Estimated net working capital adjustment related to the divestiture of Frozen Fruit	(457)	0	0
Change in short-term note receivable from divestiture of Frozen Fruit	(6,300)	0	0
Seller Promissory Notes issued on the divestiture of Frozen Fruit	(20,000)	0	0
Paid in kind interest on Seller Promissory Notes	(300)	0	0
Change in proceeds receivable from Sunflower divestiture	385	(385)	0
Change in accrued transaction costs related to the divestiture of Tradin Organic	0	0	(13,380)
Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction	0	0	(1,690)
Cash Paid
Interest	24,032	11,093	5,520
Income taxes	$ 569	$ 847	$ 3,632

Commitments and Contingencies (

Commitments and Contingencies (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Commitments And Contingencies [Line Items]
Inventory reserves	$ 6,810	$ 3,298	$ 1,604
Recall-related costs	4,842	$ 3,921
Sunrise Growers Inc [Member]
Commitments And Contingencies [Line Items]
Inventory reserves	3,000
Sunrise Growers Inc [Member] | Frozen Fruit Product Recall [Member]
Commitments And Contingencies [Line Items]
Reduction to revenues due to customer returns of the recalled products	900
Other expense	3,400
Estimated insurance recoveries, net of deductibles	4,800
Estimated insurance recoveries	4,800
Recall-related costs	$ 1,300

Disaggregation of Revenue, Ge_3

Disaggregation of Revenue, Geographic Information, and Major Customers (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 30, 2023	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Segment Reporting, Revenue Reconciling Item [Line Items]
Segment revenues from external customers	$ 181,624	$ 152,541	$ 141,163	$ 154,969	$ 159,790	$ 144,023	$ 148,065	$ 139,517	$ 630,297	$ 591,395	$ 496,455
Fruit based ingredients [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Segment revenues from external customers											$ 26,100

Disaggregation of Revenue, Ge_4

Disaggregation of Revenue, Geographic Information, and Major Customers (Disaggregated by product category) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 30, 2023	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Segment Reporting Information [Line Items]
Segment revenues from external customers	$ 181,624	$ 152,541	$ 141,163	$ 154,969	$ 159,790	$ 144,023	$ 148,065	$ 139,517	$ 630,297	$ 591,395	$ 496,455
Beverages and broths [Member]
Segment Reporting Information [Line Items]
Segment revenues from external customers									502,793	454,446	372,398
Fruit snacks [Member]
Segment Reporting Information [Line Items]
Segment revenues from external customers									98,186	82,869	62,742
Ingredients [Member]
Segment Reporting Information [Line Items]
Segment revenues from external customers									17,032	45,366	61,315
Smoothie bowls [Member]
Segment Reporting Information [Line Items]
Segment revenues from external customers									$ 12,286	$ 8,714	$ 0

Disaggregation of Revenue, Ge_5

Disaggregation of Revenue, Geographic Information, and Major Customers (Revenues from External Customers) (Details) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 30, 2023	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Segment Reporting Information [Line Items]
Segment revenues from external customers	$ 181,624	$ 152,541	$ 141,163	$ 154,969	$ 159,790	$ 144,023	$ 148,065	$ 139,517	$ 630,297	$ 591,395	$ 496,455
U.S. [Member]
Segment Reporting Information [Line Items]
Segment revenues from external customers									615,133	577,515	483,544
Canada [Member]
Segment Reporting Information [Line Items]
Segment revenues from external customers									11,740	8,973	9,319
Other [Member]
Segment Reporting Information [Line Items]
Segment revenues from external customers									$ 3,424	$ 4,907	$ 3,592

Disaggregation of Revenue, Ge_6

Disaggregation of Revenue, Geographic Information, and Major Customers (Long-Lived Assets) (Details) - USD ($) $ in Thousands	Dec. 30, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Total long-lived assets	$ 319,898	$ 292,306
U.S. [Member]
Segment Reporting Information [Line Items]
Total long-lived assets	317,830	290,266
Canada [Member]
Segment Reporting Information [Line Items]
Total long-lived assets	$ 2,068	$ 2,040

Disaggregation of Revenue, Ge_7

Disaggregation of Revenue, Geographic Information, and Major Customers (Major Customers) (Details) - Revenue Benchmark [Member] - Customer Concentration Risk [Member]	12 Months Ended
	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Customer A [Member]
Segment Reporting Information [Line Items]
Percentage of consolidated revenues from major customer	34%	31%	30%
Customer B [Member]
Segment Reporting Information [Line Items]
Percentage of consolidated revenues from major customer	8%	14%	13%

Subsequent Event (Narrative) (D

Subsequent Event (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Feb. 23, 2024	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Subsequent Event [Line Items]
Proceeds from sale of property, plant and equipment		$ 0	$ 4,182	$ 2,300
Subsequent Event [Member]
Subsequent Event [Line Items]
Proceeds from sale of property, plant and equipment	$ 6,000

Quarterly Results of Operatio_3

Quarterly Results of Operations (unaudited) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 30, 2023	Sep. 30, 2023	Jul. 01, 2023	Apr. 01, 2023	Dec. 31, 2022	Oct. 01, 2022	Jul. 02, 2022	Apr. 02, 2022	Dec. 30, 2023	Dec. 31, 2022	Jan. 01, 2022
Quarterly Financial Information Disclosure [Abstract]
Revenues	$ 181,624	$ 152,541	$ 141,163	$ 154,969	$ 159,790	$ 144,023	$ 148,065	$ 139,517	$ 630,297	$ 591,395	$ 496,455
Gross profit	25,641	20,268	18,629	24,079	23,816	25,132	27,013	23,769	88,617	99,730	81,144
Earnings (loss) from continuing operations	(1,752)	(5,680)	(11,651)	(2,827)	(427)	2,359	928	1,021	(21,910)	3,881	5,543
Earnings (loss) from discontinued operations	(9,982)	(140,143)	(7,187)	4,204	1,481	(14,293)	543	3,547	(153,108)	(8,722)	(6,715)
Net earnings (loss)	(11,734)	(145,823)	(18,838)	1,377	1,054	(11,934)	1,471	4,568	(175,018)	(4,841)	(1,172)
Dividends and accretion of preferred stock	(429)	(426)	(422)	(704)	(830)	(764)	(760)	(755)	(1,981)	(3,109)	(4,197)
Earnings (loss) attributable to common shareholders	$ (12,163)	$ (146,249)	$ (19,260)	$ 673	$ 224	$ (12,698)	$ 711	$ 3,813	$ (176,999)	$ (7,950)	$ (5,369)
Basic and diluted earnings (loss) per share
Loss from continuing operations	$ (0.02)	$ (0.05)	$ (0.1)	$ (0.03)	$ 0.01	$ 0.01	$ 0	$ 0	$ (0.21)	$ 0.01	$ 0.01
Earnings (loss) from discontinued operations	(0.09)	(1.21)	(0.06)	0.04	(0.01)	(0.13)	0.01	0.03	(1.34)	(0.08)	(0.06)
Earnings (loss) attributable to common shareholders	$ (0.11)	$ (1.26)	$ (0.17)	$ 0.01	$ 0	$ (0.12)	$ 0.01	$ 0.04	(1.55)	(0.07)	(0.05)
Diluted earnings (loss) per share:
Loss from continuing operations									(0.21)	0.01	0.01
Earnings (loss) from discontinued operations									(1.34)	(0.08)	(0.06)
Earnings (loss) attributable to common shareholders									$ (1.55)	$ (0.07)	$ (0.05)